{"gene":"WNK1","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2000,"finding":"WNK1 is a serine/threonine protein kinase that phosphorylates myelin basic protein and itself, but uniquely lacks the invariant catalytic lysine in subdomain II; instead, Lys-233 in subdomain I performs the catalytic function, as mutation of Lys-233 to Met eliminates kinase activity.","method":"In vitro kinase assay with MBP substrate, site-directed mutagenesis (K233M), sequence analysis and structural modeling based on cAMP-dependent protein kinase structure","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay combined with mutagenesis (K233M) directly confirmed the catalytic role of Lys-233; foundational paper replicated by subsequent structural studies","pmids":["10828064"],"is_preprint":false},{"year":2002,"finding":"WNK1 contains an autoinhibitory domain (conserved in all four WNKs) that suppresses kinase-domain activity; mutation of two key residues in this domain attenuates inhibition and increases kinase activity. Autophosphorylation on Ser-382 in the activation loop is required for WNK1 activity.","method":"Enzyme fragment analysis, sequence alignment, in vitro kinase assays with autoinhibitory domain constructs, site-directed mutagenesis of activation-loop Ser-382","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with defined fragments and mutagenesis in a single rigorous study; autophosphorylation site confirmed biochemically","pmids":["12374799"],"is_preprint":false},{"year":2003,"finding":"WNK1 activates the ERK5 MAP kinase pathway upstream of MEKK2 and MEKK3: WNK1 overexpression increases ERK5 activity in a MEK5-dependent manner; dominant-negative MEKK2/MEKK3 block this effect; both MEKK2 and MEKK3 co-immunoprecipitate with endogenous WNK1; WNK1 phosphorylates MEKK2 and MEKK3 in vitro and activates MEKK3 in cells; WNK1 siRNA knockdown attenuates EGF-stimulated ERK5 activation.","method":"Co-immunoprecipitation, in vitro kinase assay, dominant-negative mutant expression, siRNA knockdown, cotransfection in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, in vitro phosphorylation, and siRNA knockdown with defined phenotypic readout in a single study","pmids":["14681216"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of the WNK1 kinase domain at 1.8 Å resolution reveals that the catalytic Lys-233 emanates from strand β2 (not β3 as in all other kinases), the activation loop adopts a unique well-folded inactive conformation, and the overall architecture places WNK1 in a novel structural subfamily of serine/threonine kinases.","method":"X-ray crystallography (1.8 Å resolution), homology modeling for substrate-specificity groove identification","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure directly confirms catalytic mechanism and unique active-site architecture; consistent with earlier mutagenesis data","pmids":["15242606"],"is_preprint":false},{"year":2004,"finding":"WNK1 is phosphorylated at Thr-60 by PKB/Akt in response to IGF-1 stimulation; this phosphorylation is PI3K-dependent, occurs on endogenous WNK1, and is abolished in PDK1-null cells where PKB is inactive. Phosphorylation of Thr-60 by PKB does not directly regulate WNK1 kinase activity or localization.","method":"Phosphospecific antibody to pThr-60, PI3K inhibitor treatment (wortmannin, LY294002), PDK1-null and PDK1-knock-in ES cell experiments, peptide mapping and mutagenesis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (phosphospecific antibody, inhibitors, genetic null cells) in one rigorous study; negative finding on kinase activity also well-controlled","pmids":["14611643"],"is_preprint":false},{"year":2004,"finding":"WNK1 selectively binds to and phosphorylates synaptotagmin 2 (Syt2) within its C2 calcium-binding domains. Endogenous WNK1 and Syt2 coimmunoprecipitate and colocalize on secretory granules in INS-1 cells. WNK1-mediated phosphorylation at Thr-202 of Syt2 increases the Ca2+ concentration required for Syt2 binding to phospholipid vesicles.","method":"Co-immunoprecipitation, colocalization by fluorescence microscopy, in vitro phosphorylation assay, phospholipid-vesicle binding assay, site-directed mutagenesis (T202 mutant)","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation with mutagenesis plus co-IP and functional phospholipid-binding assay; multiple orthogonal methods in one study","pmids":["15350218"],"is_preprint":false},{"year":2005,"finding":"WNK1 and WNK4 phosphorylate and activate the STE20-family kinases SPAK and OSR1 by phosphorylating the T-loop (Thr-233 in SPAK; Thr-185 in OSR1) and a C-terminal serine (Ser-373 in SPAK; Ser-325 in OSR1). T-loop phosphorylation is required for activation; catalytically inactive WNK1 fails to activate SPAK/OSR1. WNK1 was found associated with SPAK in rat testis immunoprecipitates.","method":"Immunoprecipitation from rat testis, in vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis (T185A, T185E, S325A/E in OSR1)","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with phosphopeptide mapping and multiple mutagenesis experiments; foundational paper widely replicated","pmids":["16083423"],"is_preprint":false},{"year":2005,"finding":"WNK1 activates SGK1 by a PI3K-dependent but non-catalytic mechanism: the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1, and activated SGK1 in turn stimulates the epithelial sodium channel (ENaC) via Nedd4-2 in a WNK1-dependent manner. Phosphorylation of WNK1 Thr-58 contributes to SGK1 activation. WNK1 is also required for IGF-1-induced SGK1 activation.","method":"Cotransfection in HEK293/oocytes, deletion mutants of WNK1, PI3K inhibitor (wortmannin), siRNA depletion, Xenopus oocyte ENaC current measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America / The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal functional epistasis, domain deletion mapping, kinase-dead mutants, siRNA knockdown across two independent papers by the same group","pmids":["16006511","16081417"],"is_preprint":false},{"year":2005,"finding":"WNK1 and WNK4 interact via their kinase domains (shown by co-immunoprecipitation). WNK1 suppresses WNK4-mediated inhibition of the NCC cotransporter; this requires WNK1 catalytic activity and an intact WNK1 protein. A kinase-dead WNK1 associates with WNK4 but fails to suppress WNK4-mediated NCC inhibition. WNK1 also phosphorylates WNK4 and WNK2 in vitro.","method":"Co-immunoprecipitation, Xenopus oocyte Na+ flux assay for NCC activity, kinase-dead mutants, deletion constructs, in vitro kinase assay","journal":"The Journal of clinical investigation / The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, functional transport assay, kinase-dead controls across two independent studies","pmids":["15841204","15883153"],"is_preprint":false},{"year":2005,"finding":"WNK1 is identified as a substrate of Akt/PKB in adipocytes; insulin stimulates WNK1 phosphorylation via PI3K/Akt1/Akt2. WNK1 knockdown (siRNA) in 3T3-L1 cells significantly enhances insulin-stimulated thymidine incorporation (~2-fold) and serum-stimulated cell proliferation, identifying WNK1 as a negative regulator of mitogenesis.","method":"Immunoprecipitation with anti-pAkt-substrate antibody + mass spectrometry, siRNA depletion of Akt1/Akt2, PI3K inhibitors, thymidine incorporation assay, cell-count proliferation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mass spectrometry identification plus siRNA knockdown with defined functional readout; single lab, two orthogonal methods","pmids":["15799971"],"is_preprint":false},{"year":2006,"finding":"WNK1 phosphorylates SPAK and OSR1; the CCT (conserved C-terminal) domain of SPAK/OSR1 binds an RFXV motif present in WNK1 (and WNK4), and an intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1. SPAK/OSR1 then phosphorylate NKCC1 at Thr-203/207/212 (human). Mutation of the RFXV-binding residues within the CCT domain inhibits NKCC1 phosphorylation.","method":"In vitro kinase assay, peptide binding/affinity purification, site-directed mutagenesis of CCT domain and RFXV motif, phosphopeptide mapping, osmotic-stress stimulation of HEK-293 cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis of both binding partners, multiple substrate phosphorylation sites identified; widely replicated","pmids":["16669787"],"is_preprint":false},{"year":2006,"finding":"WNK1 is rapidly activated and phosphorylated at multiple sites including the T-loop Ser-382 upon hyperosmotic stress, possibly by transautophosphorylation. Activation coincides with SPAK/OSR1 phosphorylation/activation, and siRNA depletion of WNK1 impairs SPAK/OSR1 activity and phosphorylation under hyperosmotic conditions. Under hyperosmotic stress, WNK1 redistributes from the cytosol to vesicular structures (TGN/recycling endosomes) marked by clathrin, AP-1, and TGN46; the C-terminal non-catalytic domain mediates vesicle localization.","method":"siRNA knockdown, phospho-specific antibodies, immunofluorescence colocalization, live-cell imaging, mutational analysis of C-terminal domain, fractionation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA depletion with defined phosphorylation readout, live imaging with colocalization and mutational analysis; multiple orthogonal methods","pmids":["17190791"],"is_preprint":false},{"year":2006,"finding":"OSR1 exists in a complex with WNK1 in cells and is phosphorylated in a WNK1-dependent manner; depletion of WNK1 by siRNA reduces OSR1 kinase activity; depletion of either WNK1 or OSR1 reduces NKCC activity in HeLa cells, placing WNK1 upstream of OSR1 upstream of NKCC1 in a pathway for volume regulation.","method":"Co-immunoprecipitation, siRNA depletion of WNK1 and OSR1, in vitro OSR1 activation assay, Rb+ uptake assay for NKCC activity","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, siRNA depletion, in vitro activation, and functional transport assay; independently confirmed by multiple labs","pmids":["16832045"],"is_preprint":false},{"year":2006,"finding":"Long WNK1 (L-WNK1) inhibits the ROMK1 potassium channel by stimulating its endocytosis; the N-terminal amino acids 1–491 are sufficient for ROMK inhibition; this inhibition is synergistic with WNK4 but independent of it. The kidney-specific KS-WNK1 isoform lacks inhibitory activity but reverses L-WNK1-mediated ROMK inhibition. Dietary K+ restriction in rats increases L-WNK1 while decreasing KS-WNK1 expression.","method":"Xenopus oocyte electrophysiology (ROMK current), truncation constructs of WNK1, dietary K+ manipulation in rats with qRT-PCR/Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional oocyte system with defined domain constructs and in vivo dietary manipulation; replicated by other groups","pmids":["16428287"],"is_preprint":false},{"year":2006,"finding":"KS-WNK1 functions as a dominant-negative regulator of L-WNK1: it forms a protein complex with L-WNK1 in oocytes (co-IP) and attenuates L-WNK1 kinase activity in vitro, leading to downregulation of NCC activity in Xenopus oocytes.","method":"Co-immunoprecipitation in Xenopus oocytes, in vitro kinase assay, Xenopus oocyte Na+ flux assay (22Na+ uptake)","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP plus in vitro kinase inhibition plus functional transport assay; multiple orthogonal methods in one study","pmids":["16204408"],"is_preprint":false},{"year":2006,"finding":"WNK1 suppresses ROMK surface expression independently of WNK4 in Xenopus oocytes; this effect requires the region encompassing amino acids 502–1100 (containing the acidic motif) and is dynamin-dependent. Surprisingly, a kinase-dead WNK1 (D368A) mimics the effect, indicating ROMK inhibition does not require catalytic activity.","method":"Xenopus oocyte ROMK current measurement, kinase-dead mutant (D368A), truncation constructs, dominant-negative dynamin coexpression","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional oocyte assay with multiple WNK1 constructs and dynamin-dominant negative; single lab but multiple orthogonal approaches","pmids":["16775035"],"is_preprint":false},{"year":2006,"finding":"WNK1 and WNK4 suppress CFTR chloride channel activity when coexpressed in Xenopus oocytes. WNK4 reduces CFTR surface expression in a kinase-independent manner. WNK1 suppression of CFTR requires intact WNK1 kinase activity. WNK1 colocalizes with CFTR in pulmonary epithelial cells.","method":"Xenopus oocyte electrophysiology (CFTR Cl- current), kinase-dead WNK1, CFTR surface expression assay, immunofluorescence colocalization","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional electrophysiology with kinase-dead mutant and colocalization; single lab","pmids":["17194447"],"is_preprint":false},{"year":2006,"finding":"WNK1 overexpression in MDCKII cells increases paracellular chloride permeability 2–3-fold and induces phosphorylation of claudin-4, phenocopying effects of disease-causing WNK4 mutants.","method":"Stable WNK1-overexpressing MDCKII cell lines, Cl- flux assay, Western blot for phospho-claudin-4","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, stable overexpression with functional Cl- permeability and claudin-4 phosphorylation readouts, but no mechanistic dissection beyond overexpression","pmids":["16949040"],"is_preprint":false},{"year":2006,"finding":"WNK1 kinase domain (but not isolated autoinhibitory domain) phosphorylates WNK4 and WNK2 in vitro. WNK1 exists as a tetramer in solution (gel filtration). The WNK1 N-terminus (residues 1–222) interacts with residues 481–660 (autoinhibitory domain + coiled-coil domain) by yeast two-hybrid assay.","method":"In vitro kinase assay, gel filtration chromatography, yeast two-hybrid","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — gel filtration and yeast two-hybrid are lower-resolution methods; in vitro phosphorylation of WNK paralogs shown; single lab","pmids":["15883153"],"is_preprint":false},{"year":2007,"finding":"WNK1 directly binds to and phosphorylates Smad2. WNK1 siRNA knockdown in HeLa cells reduces Smad2 protein expression (at least partly by reducing Smad2 transcription), but also causes nuclear accumulation of phosphorylated Smad2 and increased TGF-β-mediated transcriptional responses, identifying WNK1 as a dual modulator of TGF-β–Smad2 signaling.","method":"siRNA knockdown of WNK1 in HeLa cells, Western blot for Smad2, immunofluorescence for nuclear pSmad2, in vitro kinase assay, reporter gene assay for TGF-β target genes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus in vitro phosphorylation and transcriptional reporter readout; multiple methods but single lab","pmids":["17392271"],"is_preprint":false},{"year":2008,"finding":"The HSN2 exon of WNK1 encodes a nervous system-specific exon; the WNK1/HSN2 isoform is expressed in satellite cells, Schwann cells, and sensory neurons of the peripheral nervous system and is more abundant in sensory neurons than motor neurons. Loss-of-function mutations in this exon cause HSAN type II.","method":"Immunodetection (immunofluorescence, IHC) in mouse nervous system tissues, analysis of human WNK1/HSN2 isoform expression, characterization of mutation spectrum","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct immunodetection showing cell-type-specific localization tied to a disease phenotype; characterization of isoform structure","pmids":["18521183"],"is_preprint":false},{"year":2008,"finding":"Multiple WNK1 domains interact intramolecularly to regulate ROMK1 inhibition: the N-terminal proline-rich domain (aa 1–119) is necessary and sufficient for ROMK1 inhibition; the N-linker (aa 120–220) antagonizes inhibition; the kinase domain reverses this antagonism via conserved residues Lys-233 and Asp-368 (not kinase activity per se); the autoinhibitory domain (aa 491–555) modulates the kinase domain via two critical Phe residues; and the first coiled-coil (aa 555–640) alleviates the AID effect.","method":"Xenopus oocyte ROMK current measurements with WNK1 truncation and point mutants (K233M, D368A, Phe mutations in AID)","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic domain mapping with mutagenesis in a functional oocyte system; single lab","pmids":["18550644"],"is_preprint":false},{"year":2009,"finding":"WNK1 localizes to cytoplasmic puncta in resting cells and to mitotic spindles during cell division. WNK1 knockdown causes defects in mitotic spindles, abscission failures, and reduced cell survival. These cell-division defects are independent of the WNK1 effector kinase OSR1 (OSR1 knockdown does not cause spindle defects).","method":"Immunofluorescence localization (live imaging and fixed cells), siRNA knockdown of WNK1 and OSR1, analysis of mitotic phenotypes (spindle morphology, abscission, survival)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (siRNA knockdown + spindle/abscission phenotype), and negative control (OSR1 KD has no effect); single lab","pmids":["21220314"],"is_preprint":false},{"year":2009,"finding":"WNK1 interacts with LINGO-1 (identified by yeast two-hybrid, validated by FRET and co-IP) in cortical neurons. This interaction is intensified by Nogo66 treatment. WNK1 suppression or overexpression of a dominant-negative WNK1 fragment attenuates Nogo66-induced inhibition of neurite extension and reduces RhoA activation. WNK1 also interacts with Rho-GDI1, an interaction weakened by Nogo66.","method":"Yeast two-hybrid screen, FRET, co-immunoprecipitation, siRNA knockdown, RhoA pull-down activity assay, neurite extension assay in cortical neurons","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal binding methods (Y2H, FRET, Co-IP) plus functional siRNA/dominant-negative data; single lab","pmids":["19363035"],"is_preprint":false},{"year":2009,"finding":"WNK1 kinase uses a random sequential mechanism to phosphorylate its substrate OSR1 (OXSR1), as shown by double-reciprocal kinetic analysis. ATP-competitive inhibitors PP1 and PP2 inhibit WNK1 with Ki ~12.7 μM (PP1), acting as pure ATP competitors.","method":"Microfluidic capillary-electrophoresis kinase assay, double-reciprocal (Lineweaver-Burk) kinetic analysis, inhibitor competition assays","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro kinetic mechanism established with a rigorous assay format; single lab, single study","pmids":["19739668"],"is_preprint":false},{"year":2009,"finding":"Endothelial-specific deletion of Wnk1 in mice phenocopies global Wnk1 knockout (cardiovascular developmental defects: small heart chambers, reduced trabeculation, defective angiogenesis starting at E10.5); endothelial-specific transgenic rescue of WNK1 corrects these defects, establishing that WNK1 function in endothelial cells is required for angiogenesis and heart development.","method":"Conditional endothelial-specific Cre-mediated Wnk1 knockout, transgenic rescue with endothelial WNK1 expression, embryo phenotype analysis","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional knockout plus transgenic rescue constitutes genetic epistasis with defined cellular phenotype; replicated across multiple labs","pmids":["19644017"],"is_preprint":false},{"year":2010,"finding":"WNK1 promotes cell-surface expression of GLUT1 by phosphorylating TBC1D4 (AS160) in vitro, which increases TBC1D4 binding to 14-3-3 proteins and reduces its interaction with the exocytic GTPase Rab8A. This effect requires WNK1 catalytic activity (kinase-dead WNK1 has no effect).","method":"Co-immunoprecipitation (WNK1-TBC1D4 complex), in vitro kinase assay, 14-3-3 and Rab8A binding assays, surface GLUT1 expression measurement, kinase-dead WNK1 mutant","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, in vitro phosphorylation, multiple protein-interaction readouts, kinase-dead control; single lab","pmids":["20937822"],"is_preprint":false},{"year":2011,"finding":"WNK1 stimulates PLC-β signaling by promoting synthesis of the PIP2 substrate via activation of phosphatidylinositol 4-kinase IIIα (PI4KIIIα). This effect does not require WNK1 kinase activity and is synergistic with Gαq. WNK1 activity is essential for Gq-coupled receptor regulation of PLC-β. Akt-mediated phosphorylation of WNK1 further amplifies PLC-β signaling via this mechanism.","method":"DAG biosensor (TRPC6) and IP3-Ca2+ reporter assays in cells, WNK1 kinase-dead mutant, PI4KIIIα manipulation, Gq inhibitors","journal":"Current biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cellular biosensor assays with kinase-dead mutant, multiple signaling pathway manipulations; single lab","pmids":["22119528"],"is_preprint":false},{"year":2013,"finding":"WNK1 activates OSR1 downstream to regulate embryonic angiogenesis and cardiac development: global Osr1 deletion phenocopies Wnk1 knockout (identical yolk-sac and embryo angiogenesis defects from E11); endothelial-specific active-OSR1 transgene rescues cardiovascular defects in global Wnk1-null embryos, establishing a WNK1→OSR1 epistatic axis in embryonic cardiovascular development.","method":"Genetic epistasis: global Osr1 knockout, endothelial-specific Osr1 knockout (Tie2-Cre), constitutively active OSR1 knock-in at ROSA26, embryo phenotype analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous genetic epistasis with conditional knockout and transgenic rescue in multiple mouse lines; confirms the WNK1–OSR1 axis in vivo","pmids":["23386621"],"is_preprint":false},{"year":2014,"finding":"Chloride directly binds to the catalytic site of WNK1, stabilizing its inactive conformation and inhibiting autophosphorylation. Crystallographic studies of inactive WNK1 in the presence of chloride reveal the Cl- binding site in the active site cavity. Mutagenesis of the chloride-binding site renders WNK1 less sensitive to chloride-mediated inhibition of autophosphorylation, validating WNK1 as a chloride sensor.","method":"X-ray crystallography of WNK1 kinase domain with chloride, autophosphorylation assays under varying Cl- concentrations, site-directed mutagenesis of Cl-binding site residues","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with Cl- plus mutagenesis validating the binding site plus biochemical autophosphorylation assay; multiple orthogonal methods in one rigorous study","pmids":["24803536"],"is_preprint":false},{"year":2014,"finding":"WNK1 and its substrate kinase OSR1 have distinct roles in endothelial cells: OSR1 is required for HUVEC chemotaxis and invasion, while SPAK is required for endothelial cell proliferation. WNK1 loss of function impairs cord formation. WNK1 also regulates expression of the transcription factor Slug in endothelial cells.","method":"siRNA knockdown of WNK1, OSR1, and SPAK in HUVECs, Matrigel cord-formation assay, chemotaxis/invasion assay, proliferation assay, gene expression analysis for Slug","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts separating OSR1/SPAK functions; single lab","pmids":["25362046"],"is_preprint":false},{"year":2014,"finding":"KLHL3 mediates ubiquitination and degradation of WNK1 (and WNK4) as part of the KLHL3-Cullin3 E3 ligase complex; KLHL3 R528H mutation impairs binding to WNK1 and WNK4 peptides, leading to increased WNK1 and WNK4 protein levels and hyperactivation of the WNK→OSR1/SPAK→NCC phosphorylation cascade, causing PHAII.","method":"KLHL3 R528H knock-in mouse model, Western blot for WNK1/WNK4 protein levels, fluorescence correlation spectroscopy peptide-binding assay, NCC phosphorylation analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo knock-in mouse model plus direct peptide-binding assay for KLHL3-WNK1 interaction; multiple methods confirming degradation pathway","pmids":["24821705"],"is_preprint":false},{"year":2014,"finding":"WNK1-OSR1-mediated phosphorylation of NKCC1 is required for regulatory volume increase and promotes glioma cell migration. siRNA-mediated knockdown of WNK1 or OSR1 reduces intracellular K+ and Cl- content, abolishes NKCC1 phospho-activation, and significantly decreases glioma cell migration following temozolomide treatment.","method":"siRNA knockdown of WNK1 and OSR1, fluorescent ion indicators for intracellular K+/Cl-, microchemotaxis migration assay, NKCC1 phosphorylation Western blot","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with ion transport and migration functional readouts; single lab","pmids":["24555568"],"is_preprint":false},{"year":2015,"finding":"WNK1 isoforms containing PY-motif-bearing alternatively spliced exons within a proline-rich region are substrates of the E3 ligase NEDD4-2 and are degraded by the ubiquitin-proteasome system. SGK1 (aldosterone-induced kinase) phosphorylates NEDD4-2 and prevents WNK1 degradation, thereby linking aldosterone to activation of the WNK/SPAK/OSR1/NCC pathway. WNK1 deficiency negates regulatory effects of NEDD4-2 and SGK1 on NCC.","method":"Identification of PY-motif exons by cDNA analysis, co-IP of WNK1 with NEDD4-2, proteasome inhibitor experiments, SGK1 activity assays, gene-edited WNK1-deficient cells, aldosterone infusion in WT and Nedd4-2 KO mice","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, proteasome inhibition, gene-editing, in vivo aldosterone), linking post-translational regulation to function","pmids":["26241057"],"is_preprint":false},{"year":2016,"finding":"WNK1 negatively regulates integrin-mediated T cell adhesion while positively regulating T cell migration via OXSR1/STK39 (OSR1/SPAK) and SLC12A2 (NKCC1). WNK1-deficient T cells (identified by RNAi screen) home less efficiently to lymphoid organs and migrate more slowly through them.","method":"RNAi screen, conditional T cell-specific knockout, cell migration and adhesion assays in vitro, in vivo homing assay to lymphoid organs","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi screen plus conditional knockout with in vitro and in vivo functional readouts; published in high-tier journal with defined pathway placement","pmids":["27400149"],"is_preprint":false},{"year":2016,"finding":"WNK1 inhibits autophagy by multiple mechanisms: WNK1 depletion increases autophagosome formation and autophagic flux, stimulates PI3KC3 complex activity, increases ULK1 expression and AMPK-mediated phosphorylation. The N-terminal region of WNK1 binds UVRAG (a PI3KC3 component) in vitro and WNK1 partially colocalizes with UVRAG; colocalization decreases upon starvation. Depletion of SPAK (but not OSR1) also induces autophagy.","method":"siRNA knockdown of WNK1, autophagosome/flux assays, ULK1 expression and phosphorylation Western blot, AMPK activation assay, in vitro binding of WNK1 N-terminus to UVRAG, colocalization by fluorescence microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple downstream readouts and in vitro binding; single lab but multiple orthogonal methods","pmids":["27911840"],"is_preprint":false},{"year":2017,"finding":"The KS-WNK1 isoform is critical for WNK body formation in distal tubule cells. WNK bodies are dynamic, membraneless foci distinct from conventional organelles that colocalize with ribosomal protein L22 and cluster WNK signaling components. KS-WNK1 knockout mice fail to form WNK bodies under dietary K+ challenge. A cysteine-rich hydrophobic motif in KS-WNK1's unique N-terminal exon is required for WNK body formation.","method":"KS-WNK1 knockout mouse model, live-cell imaging of WNK bodies, colocalization with organelle markers, reconstitution in cell culture, mutagenesis of the cysteine-rich motif","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse plus cell reconstitution plus mutagenesis; single lab with multiple methods","pmids":["29237822"],"is_preprint":false},{"year":2017,"finding":"GABA_A receptor-mediated synaptic inhibition regulates KCC2 surface expression via the Cl--sensing kinase WNK1: enhanced GABA_A inhibition confines KCC2 to the plasma membrane, while blocking inhibition increases KCC2 lateral diffusion and endocytosis. This mechanism is dependent on WNK1-mediated phosphorylation of KCC2 at Thr-906 and Thr-1007.","method":"Single-particle tracking of KCC2 in hippocampal neurons, pharmacological manipulation of GABA_A activity, phospho-specific antibodies for KCC2 Thr-906/1007, WNK1 inhibitor experiments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — single-particle tracking plus pharmacology plus phospho-specific antibodies with functional readout; published in high-tier journal","pmids":["29176664"],"is_preprint":false},{"year":2017,"finding":"WNK1 phosphorylates the transcription termination factor PCF11 on its CID (CTD-interacting domain), and this phosphorylation weakens the CID's interaction with RNA polymerase II CTD, thereby promoting transcript release from chromatin-associated Pol II and facilitating mRNA export.","method":"In vitro kinase assay (WNK1 phosphorylation of PCF11 CID), phosphorylation-dependent Pol II CTD binding assay, nuclear WNK1 localization, mRNA export assay","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay plus Pol II CTD binding assay with functional mRNA export readout; single lab","pmids":["29196535"],"is_preprint":false},{"year":2019,"finding":"WNK1 activates TRPC6-mediated Ca2+ influx by stimulating PI4KIIIα, activating Gαq-coupled/PLC-β signaling and downstream NFATc1, promoting proliferation and migration of clear-cell renal carcinoma cells. Inhibition of WNK1 attenuates TRPC6-mediated Ca2+ influx and NFATc1-dependent gene expression.","method":"Patch-clamp electrophysiology for TRPC6 current, Ca2+ imaging, PI4KIIIα activity assay, NFATc1 reporter assay, WNK1 siRNA knockdown and pharmacological inhibition, cell migration/proliferation assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology, Ca2+ imaging, and kinase-pathway analysis with siRNA/inhibitor; single lab","pmids":["31022353"],"is_preprint":false},{"year":2020,"finding":"Mutations in the conserved acidic motif of WNK1 preferentially impair ubiquitination and degradation of the KS-WNK1 isoform (not L-WNK1) by the KLHL3-CUL3 E3 ligase complex, leading to increased SPAK-NCC phosphorylation cascade activity and impaired ROMK apical expression in the distal nephron, causing a normotenive hyperkalemic hyperchloremic acidosis.","method":"Exome sequencing, Xenopus oocyte and HEK293T functional assays for ubiquitination and NCC activity, CRISPR/Cas9 engineered mouse model, renal phospho-NCC and ROMK expression analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — human genetics plus functional cell assays plus CRISPR mouse model with renal molecular phenotyping; multiple orthogonal methods","pmids":["32790646"],"is_preprint":false},{"year":2021,"finding":"WNK1 functions as an assembly factor for the human ER membrane protein complex (EMC): WNK1 uses a conserved amphipathic helix to stabilize the soluble EMC subunit EMC2 by binding at the EMC2-8 interface, shielding a hydrophobic surface from promiscuous interactions and competing with E3 ubiquitin ligases to permit proper EMC assembly. WNK1 depletion destabilizes both EMC and its membrane-protein clients.","method":"Biochemical reconstitution, co-immunoprecipitation of WNK1 with EMC2/EMC subunits, structural analysis of amphipathic helix interaction, E3 ligase competition binding assay, WNK1 depletion with analysis of EMC client stability","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution plus structural interface mapping plus E3 ligase competition assay plus depletion phenotype; multiple orthogonal methods; single rigorous study","pmids":["33964204"],"is_preprint":false},{"year":2021,"finding":"WNK1 negatively regulates NLRP3 inflammasome activation and pyroptosis by balancing intracellular Cl- and K+ concentrations. WNK1-deficient macrophages (kinase knockout or protein knockout) show increased NLRP3 activation and pyroptosis. Macrophage-specific WNK1 conditional knockout mice produce more IL-1β in response to NLRP3 stimulation.","method":"WNK1 kinase-inactive and protein-knockout macrophages, NLRP3 activation assays (IL-1β secretion, pyroptosis), macrophage-specific conditional knockout mouse model, intracellular Cl-/K+ measurement","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional macrophage KO mouse in vivo plus cell-based kinase and protein knockouts with multiple functional readouts; well-controlled mechanistic link to Cl-/K+ sensing","pmids":["34315884"],"is_preprint":false},{"year":2022,"finding":"WNK1 acts as a chloride-stimulated scaffold (kinase-activity independent) that recruits SGK1 to mTORC2, resulting in enhanced SGK1 phosphorylation and SGK1-dependent ENaC activation. An increase in extracellular K+ raises intracellular Cl-, which triggers this WNK1 scaffolding activity. This effect is selective for SGK1 and does not cause generalized mTORC2 activation.","method":"Co-immunoprecipitation of WNK1-SGK1-mTORC2, kinase-dead WNK1 mutant experiments, intracellular Cl- manipulation, ENaC activity assay, SGK1 phosphorylation Western blot","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of ternary complex plus kinase-dead mutant plus ion manipulation with functional ENaC readout; single lab but multiple methods","pmids":["36373794"],"is_preprint":false},{"year":2022,"finding":"WNK1 inhibition prevents TGF-β-dependent degradation of the tyrosine kinase receptor AXL in endothelial cells, and OSR1 (WNK1 substrate) physically interacts with occludin (a tight junction protein), a step required for tight junction turnover during angiogenesis. Both phenomena are WNK1-dependent and TGF-β-sensitive.","method":"WNK1 inhibitor treatment of HUVECs and aortic ex vivo sprouting assay, co-immunoprecipitation of OSR1-occludin, AXL expression/degradation assay in presence/absence of WNK1 inhibitor, embryo vessel extension assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for OSR1-occludin, pharmacological WNK1 inhibition with functional angiogenesis and AXL degradation readouts; multiple methods, single lab","pmids":["35867836"],"is_preprint":false}],"current_model":"WNK1 is a structurally unique serine/threonine kinase (catalytic Lys-233 in β2 rather than β3) that functions as a chloride-sensing master regulator: intracellular Cl- directly binds the active site to inhibit autophosphorylation and keep WNK1 inactive, whereas low Cl- allows T-loop (Ser-382) autophosphorylation and activation; active WNK1 then phosphorylates and activates the STE20-family kinases SPAK and OSR1 (via their T-loops and RFXV–CCT docking), which in turn phosphorylate and activate NKCC1/NKCC2 while inhibiting KCC2, thereby coordinating epithelial and neuronal ion homeostasis; WNK1 also activates SGK1 (through a non-catalytic PI3K-dependent scaffolding that recruits SGK1 to mTORC2) to regulate ENaC, phosphorylates synaptotagmin 2 to modulate Ca²⁺-sensing, activates the ERK5 MAPK cascade via MEKK2/3, and inhibits autophagy by binding UVRAG; it undergoes PKB/Akt-mediated phosphorylation at Thr-60 downstream of insulin/IGF-1 and is regulated by ubiquitin-mediated proteasomal degradation through the KLHL3-Cullin3 E3 ligase; additionally, WNK1 serves as an assembly factor for the ER membrane protein complex (EMC) via a conserved amphipathic helix, and in the nucleus it phosphorylates the termination factor PCF11 to facilitate mRNA export; the kidney-specific KS-WNK1 isoform (lacking the kinase domain) antagonizes L-WNK1 by direct protein interaction and is required for formation of membraneless WNK signaling bodies in distal tubule cells, while the nervous-system-specific WNK1/HSN2 isoform regulates KCC2 phosphorylation and is required for peripheral sensory neuron development."},"narrative":{"mechanistic_narrative":"WNK1 is a structurally atypical serine/threonine kinase that functions as a master regulator of intracellular ion homeostasis and a chloride sensor coupling chloride concentration to cell-signaling output [PMID:10828064, PMID:24803536]. It is catalytically unique: the active-site lysine (Lys-233) emanates from strand β2 rather than β3, and a high-resolution crystal structure places WNK1 in a novel kinase subfamily with an autoinhibited activation loop [PMID:10828064, PMID:15242606]. Activity is gated by autophosphorylation of activation-loop Ser-382, which is relieved from an intramolecular autoinhibitory domain; intracellular chloride binds directly within the active-site cavity to stabilize the inactive state and suppress autophosphorylation, making WNK1 sensitive to changes in Cl- [PMID:12374799, PMID:24803536]. The central effector axis is the phosphorylation and activation of the STE20-family kinases SPAK and OSR1, which WNK1 engages through an RFXV motif that docks the SPAK/OSR1 CCT domain and which it activates by T-loop phosphorylation; activated OSR1/SPAK in turn phosphorylate the cation-chloride cotransporter NKCC1 and the K-Cl cotransporter KCC2 to set epithelial and neuronal ion balance [PMID:16083423, PMID:16669787, PMID:16832045, PMID:29176664]. Through this cascade WNK1 governs cell-volume regulation, NCC/ROMK activity in the distal nephron, T-cell adhesion and migration, and macrophage NLRP3 inflammasome activation via Cl-/K- balancing [PMID:16428287, PMID:24555568, PMID:27400149, PMID:34315884]. Beyond catalysis, WNK1 acts as a non-catalytic scaffold: it recruits SGK1 to mTORC2 in a chloride-stimulated, kinase-independent manner to activate ENaC, and serves as an assembly factor for the ER membrane protein complex through a conserved amphipathic helix that stabilizes EMC2 [PMID:33964204, PMID:36373794]. WNK1 abundance is controlled by ubiquitin-mediated proteasomal degradation through the KLHL3-Cullin3 E3 ligase and through NEDD4-2 acting on PY-motif-bearing isoforms, with both pathways feeding into the WNK→SPAK/OSR1→NCC cascade [PMID:24821705, PMID:26241057, PMID:32790646]. WNK1 is required in vivo for endothelial angiogenesis and cardiac development via an OSR1-dependent axis, and tissue-specific isoforms diversify its function: the kinase-domain-lacking KS-WNK1 antagonizes L-WNK1 and nucleates membraneless WNK signaling bodies in distal tubule cells, while a nervous-system-specific WNK1/HSN2 isoform is expressed in peripheral sensory neurons [PMID:19644017, PMID:23386621, PMID:29237822, PMID:18521183]. Loss-of-function mutations in the WNK1/HSN2 exon cause hereditary sensory and autonomic neuropathy type II, and impaired KLHL3/KS-WNK1 degradation underlies pseudohypoaldosteronism type II [PMID:18521183, PMID:32790646].","teleology":[{"year":2000,"claim":"Established that WNK1 is an active serine/threonine kinase with an unprecedented catalytic architecture, answering whether and how a kinase lacking the canonical subdomain-II lysine could function.","evidence":"In vitro kinase assay on MBP plus K233M mutagenesis and structural modeling","pmids":["10828064"],"confidence":"High","gaps":["Physiological substrates not yet identified","Regulation of activity in cells unknown"]},{"year":2002,"claim":"Defined how WNK1 activity is controlled, showing an autoinhibitory domain suppresses the kinase and that activation-loop Ser-382 autophosphorylation is required for activity.","evidence":"In vitro kinase assays with autoinhibitory-domain fragments and Ser-382 mutagenesis","pmids":["12374799"],"confidence":"High","gaps":["Upstream signal triggering activation not defined","Whether autophosphorylation is cis or trans unresolved"]},{"year":2004,"claim":"Provided atomic-resolution confirmation of the unique active-site geometry (Lys-233 from β2) and an inactive activation-loop conformation, placing WNK1 in a distinct structural subfamily.","evidence":"X-ray crystallography of the WNK1 kinase domain at 1.8 Å","pmids":["15242606"],"confidence":"High","gaps":["Structure of active/phosphorylated state not captured","No substrate-bound complex"]},{"year":2003,"claim":"Connected WNK1 to MAPK signaling by showing it acts upstream of MEKK2/3 to activate the ERK5 cascade, broadening its role beyond ion transport.","evidence":"Reciprocal Co-IP, in vitro phosphorylation of MEKK2/3, dominant-negative and siRNA in HEK293","pmids":["14681216"],"confidence":"High","gaps":["Physiological context of ERK5 activation by WNK1 unclear","In vivo relevance not tested"]},{"year":2004,"claim":"Placed WNK1 downstream of insulin/IGF-1 signaling by identifying PKB/Akt phosphorylation at Thr-60, while showing this does not directly alter kinase activity.","evidence":"Phosphospecific antibody, PI3K inhibitors, PDK1-null cells, peptide mapping","pmids":["14611643"],"confidence":"High","gaps":["Functional consequence of Thr-60 phosphorylation initially unclear","Downstream effectors of this input not defined here"]},{"year":2004,"claim":"Identified a neuronal/secretory substrate, synaptotagmin 2, demonstrating WNK1 can tune Ca2+-sensing of vesicle fusion machinery.","evidence":"Co-IP, colocalization on granules, in vitro phosphorylation at Thr-202, phospholipid-binding assay","pmids":["15350218"],"confidence":"High","gaps":["In vivo relevance to secretion not established","Cell-type specificity of this function unknown"]},{"year":2005,"claim":"Defined the core effector axis: WNK1 phosphorylates and activates SPAK and OSR1 via their T-loops, establishing the kinase cascade that controls ion cotransporters.","evidence":"In vitro kinase assay, phosphopeptide mapping, T-loop/C-terminal mutagenesis, testis IP","pmids":["16083423"],"confidence":"High","gaps":["Substrate selection mechanism not fully defined","In vivo cotransporter consequences shown later"]},{"year":2005,"claim":"Revealed a non-catalytic scaffolding function in which WNK1's N-terminus activates SGK1 (PI3K-dependent) to stimulate ENaC via Nedd4-2, distinguishing kinase-independent from kinase-dependent WNK1 roles.","evidence":"Domain deletions, kinase-dead mutants, siRNA, Xenopus oocyte ENaC currents","pmids":["16006511","16081417"],"confidence":"High","gaps":["Molecular details of SGK1 recruitment defined later","Chloride dependence not yet appreciated"]},{"year":2005,"claim":"Showed WNK kinases interact and cross-regulate, with catalytically active WNK1 suppressing WNK4-mediated NCC inhibition, linking WNK1 to renal sodium handling.","evidence":"Co-IP, kinase-dead controls, in vitro phosphorylation of WNK paralogs, oocyte Na+ flux","pmids":["15841204","15883153"],"confidence":"High","gaps":["In vivo NCC regulation by WNK1 not directly tested here","Stoichiometry of WNK1-WNK4 complex unclear"]},{"year":2005,"claim":"Identified WNK1 as an Akt substrate in adipocytes and a negative regulator of mitogenesis, linking insulin signaling to proliferation control.","evidence":"Anti-pAkt-substrate IP/MS, siRNA, thymidine incorporation and proliferation assays in 3T3-L1","pmids":["15799971"],"confidence":"Medium","gaps":["Mechanism by which WNK1 restrains proliferation unknown","Single cell-line context"]},{"year":2006,"claim":"Defined the docking logic of the WNK→SPAK/OSR1→NKCC1 cascade, showing the SPAK/OSR1 CCT domain binds the WNK1 RFXV motif and is required for efficient substrate phosphorylation.","evidence":"In vitro kinase assays, peptide-binding, CCT/RFXV mutagenesis, NKCC1 phosphosite mapping","pmids":["16669787"],"confidence":"High","gaps":["How osmotic stress triggers WNK1 not yet at chloride-level detail","Other RFXV-bearing partners not enumerated"]},{"year":2006,"claim":"Placed WNK1 functionally upstream of OSR1 and NKCC in cell-volume regulation and showed osmotic-stress-induced WNK1 activation and vesicular relocalization.","evidence":"Co-IP, siRNA of WNK1/OSR1, in vitro OSR1 activation, Rb+ uptake, live imaging and fractionation","pmids":["16832045","17190791"],"confidence":"High","gaps":["Direct osmosensing mechanism not yet defined","Functional role of vesicular relocalization unclear"]},{"year":2006,"claim":"Established L-WNK1 versus KS-WNK1 isoform antagonism in the kidney, showing L-WNK1 inhibits ROMK endocytically (partly kinase-independent) while KS-WNK1 reverses this, defining isoform-based regulation of renal K+ handling.","evidence":"Oocyte ROMK electrophysiology, truncations, kinase-dead (D368A), dynamin DN, Co-IP, dietary K+ in rats","pmids":["16428287","16204408","16775035","18550644"],"confidence":"High","gaps":["Structural basis of intramolecular domain regulation incomplete","In vivo ROMK regulation tied to physiology shown later"]},{"year":2006,"claim":"Extended WNK1's channel-regulatory reach to CFTR and paracellular permeability, indicating broad control of epithelial chloride flux.","evidence":"Oocyte CFTR currents with kinase-dead WNK1; MDCKII Cl- flux and phospho-claudin-4","pmids":["17194447","16949040"],"confidence":"Medium","gaps":["Single-lab overexpression systems","Direct substrate of claudin-4 phosphorylation not shown to be WNK1"]},{"year":2007,"claim":"Identified WNK1 as a dual modulator of TGF-β–Smad2 signaling, binding and phosphorylating Smad2 and controlling its levels and nuclear activity.","evidence":"siRNA, Western blot, nuclear pSmad2 immunofluorescence, in vitro kinase, reporter assay in HeLa","pmids":["17392271"],"confidence":"Medium","gaps":["Phosphosite on Smad2 not mapped","Transcriptional versus post-translational contributions intertwined"]},{"year":2008,"claim":"Characterized the nervous-system-specific WNK1/HSN2 isoform and linked its loss-of-function to hereditary sensory and autonomic neuropathy type II, tying WNK1 to peripheral sensory neuron biology.","evidence":"Immunodetection in mouse nervous tissue, human isoform expression and mutation spectrum analysis","pmids":["18521183"],"confidence":"Medium","gaps":["Molecular function of HSN2 isoform not defined","Mechanism linking mutations to neuropathy unclear"]},{"year":2009,"claim":"Revealed an OSR1-independent role of WNK1 in mitosis, with localization to spindles and knockdown causing spindle and abscission defects.","evidence":"Immunofluorescence/live imaging, siRNA of WNK1 and OSR1, mitotic phenotype analysis","pmids":["21220314"],"confidence":"Medium","gaps":["Mitotic substrates of WNK1 not identified","Mechanism of spindle association unknown"]},{"year":2009,"claim":"Connected WNK1 to neuronal Nogo/RhoA inhibitory signaling through interaction with LINGO-1 and Rho-GDI1, implicating it in neurite outgrowth control.","evidence":"Y2H, FRET, Co-IP, siRNA, RhoA pull-down, neurite extension in cortical neurons","pmids":["19363035"],"confidence":"Medium","gaps":["Whether kinase activity is required not resolved","Single-lab interaction data"]},{"year":2009,"claim":"Defined the enzymatic mechanism of WNK1 toward OSR1 as random sequential and characterized ATP-competitive inhibition, enabling biochemical inhibitor work.","evidence":"Microfluidic capillary-electrophoresis kinase assay, Lineweaver-Burk kinetics, PP1/PP2 competition","pmids":["19739668"],"confidence":"Medium","gaps":["Inhibitors are non-selective tool compounds","Single in vitro study"]},{"year":2013,"claim":"Established the WNK1→OSR1 axis as essential for embryonic angiogenesis and cardiac development in vivo via genetic epistasis and endothelial rescue.","evidence":"Global and endothelial Wnk1/Osr1 knockouts, constitutively active OSR1 knock-in rescue, embryo phenotyping","pmids":["19644017","23386621"],"confidence":"High","gaps":["Downstream effectors of OSR1 in endothelium not fully defined here","Cotransporter contribution to vascular phenotype unclear"]},{"year":2014,"claim":"Identified chloride as a direct allosteric ligand binding the WNK1 active site to inhibit autophosphorylation, establishing WNK1 as a bona fide chloride sensor.","evidence":"X-ray crystallography with Cl-, autophosphorylation assays across Cl- concentrations, Cl--site mutagenesis","pmids":["24803536"],"confidence":"High","gaps":["How physiological Cl- transients are integrated in cells not fully resolved","Other ion sensitivities not excluded"]},{"year":2014,"claim":"Connected the WNK1-OSR1-NKCC1 axis to disease-relevant cell behavior, showing it drives glioma volume regulation and migration.","evidence":"siRNA of WNK1/OSR1, intracellular K+/Cl- indicators, NKCC1 phospho Western, migration assays","pmids":["24555568"],"confidence":"Medium","gaps":["In vivo tumor relevance not tested","Single cell-context"]},{"year":2014,"claim":"Defined ubiquitin-mediated control of WNK1 abundance by the KLHL3-Cullin3 ligase, and showed disease mutations stabilizing WNK1 hyperactivate the NCC cascade in PHAII.","evidence":"KLHL3 R528H knock-in mouse, peptide-binding (FCS), WNK1/WNK4 Western, NCC phosphorylation","pmids":["24821705"],"confidence":"High","gaps":["Degron determinants on WNK1 not fully mapped here","Isoform selectivity of degradation addressed later"]},{"year":2014,"claim":"Dissected divergent roles of WNK1 effectors in endothelial cells, with OSR1 driving chemotaxis/invasion and SPAK driving proliferation, plus regulation of Slug.","evidence":"siRNA of WNK1/OSR1/SPAK in HUVECs, cord-formation, chemotaxis/invasion, proliferation, gene expression","pmids":["25362046"],"confidence":"Medium","gaps":["Mechanism of Slug regulation unknown","Single-lab cell-based data"]},{"year":2015,"claim":"Linked aldosterone signaling to WNK1 stability, showing SGK1-phosphorylated NEDD4-2 spares PY-motif WNK1 isoforms from degradation to activate the NCC pathway.","evidence":"PY-motif exon analysis, Co-IP with NEDD4-2, proteasome inhibition, gene-edited cells, aldosterone infusion in mice","pmids":["26241057"],"confidence":"High","gaps":["Quantitative contribution relative to KLHL3 pathway unclear","Isoform-specific effects not fully resolved"]},{"year":2016,"claim":"Established a physiological immune role, with WNK1 (via OXSR1/STK39 and SLC12A2) negatively regulating T-cell adhesion while promoting migration and lymphoid homing.","evidence":"RNAi screen, T-cell conditional knockout, adhesion/migration assays, in vivo homing","pmids":["27400149"],"confidence":"High","gaps":["How TCR/chemokine signals activate WNK1 in T cells not fully defined","Chloride-sensing contribution in T cells unaddressed"]},{"year":2016,"claim":"Identified WNK1 as a negative regulator of autophagy, acting partly through binding the PI3KC3 component UVRAG and through SPAK.","evidence":"siRNA, autophagosome/flux assays, ULK1/AMPK Western, in vitro WNK1 N-terminus–UVRAG binding, colocalization","pmids":["27911840"],"confidence":"Medium","gaps":["Whether kinase activity is required not fully resolved","Direct versus indirect effects on PI3KC3 unclear"]},{"year":2017,"claim":"Demonstrated a nuclear, transcription-associated function: WNK1 phosphorylates the termination factor PCF11 to weaken its Pol II CTD interaction and promote transcript release and mRNA export.","evidence":"In vitro kinase on PCF11 CID, phosphorylation-dependent CTD binding, nuclear localization, mRNA export assay","pmids":["29196535"],"confidence":"Medium","gaps":["In vivo significance for gene expression not established","Single-lab study"]},{"year":2017,"claim":"Showed WNK1 couples GABA_A inhibitory activity to KCC2 surface stability via phosphorylation at Thr-906/1007, integrating chloride sensing with neuronal inhibition.","evidence":"Single-particle tracking of KCC2, GABA_A pharmacology, phospho-specific antibodies, WNK1 inhibition","pmids":["29176664"],"confidence":"High","gaps":["Direct versus SPAK/OSR1-mediated KCC2 phosphorylation not fully separated","In vivo neuronal consequences not tested here"]},{"year":2017,"claim":"Established that the KS-WNK1 isoform nucleates membraneless WNK signaling bodies in distal tubule cells, providing a spatial organizing principle for the pathway under K+ challenge.","evidence":"KS-WNK1 knockout mouse, live imaging, colocalization, cell reconstitution, cysteine-rich motif mutagenesis","pmids":["29237822"],"confidence":"Medium","gaps":["Biophysical basis of body formation incompletely defined","Functional output of WNK bodies on signaling not fully quantified"]},{"year":2019,"claim":"Showed WNK1 drives TRPC6-mediated Ca2+ influx via PI4KIIIα/PLC-β/NFATc1, promoting renal carcinoma proliferation and migration, extending the non-catalytic PLC pathway to cancer.","evidence":"Patch-clamp, Ca2+ imaging, PI4KIIIα activity, NFATc1 reporter, siRNA/inhibitor, migration assays","pmids":["31022353","22119528"],"confidence":"Medium","gaps":["In vivo tumor relevance not established","Kinase-independence of the full pathway not exhaustively tested"]},{"year":2020,"claim":"Refined disease genetics by showing acidic-motif mutations selectively impair KS-WNK1 (not L-WNK1) degradation by KLHL3-CUL3, causing a hyperkalemic hyperchloremic acidosis via NCC and ROMK dysregulation.","evidence":"Exome sequencing, oocyte/HEK293T ubiquitination and NCC assays, CRISPR mouse, renal phospho-NCC/ROMK analysis","pmids":["32790646"],"confidence":"High","gaps":["Mechanism of isoform-selective degron recognition not fully resolved","Quantitative contribution of ROMK versus NCC to phenotype unclear"]},{"year":2021,"claim":"Uncovered a kinase-independent moonlighting role as an EMC assembly factor, with a WNK1 amphipathic helix stabilizing EMC2 against degradation to permit ER membrane protein complex assembly.","evidence":"Reconstitution, Co-IP with EMC2/EMC subunits, interface structural analysis, E3-ligase competition, depletion of EMC clients","pmids":["33964204"],"confidence":"High","gaps":["How this function is partitioned from ion-signaling roles unknown","In vivo importance not assessed"]},{"year":2021,"claim":"Established WNK1 as a brake on innate immune activation, negatively regulating NLRP3 inflammasome and pyroptosis by balancing intracellular Cl-/K+.","evidence":"Kinase-inactive and protein-knockout macrophages, IL-1β/pyroptosis assays, macrophage-specific conditional KO mouse, ion measurement","pmids":["34315884"],"confidence":"High","gaps":["Relative roles of kinase versus scaffold functions partially defined","Direct effector linking WNK1 to NLRP3 not pinpointed"]},{"year":2022,"claim":"Defined the molecular basis of WNK1-mediated SGK1 activation as chloride-stimulated scaffolding that recruits SGK1 to mTORC2 selectively, integrating extracellular K+/intracellular Cl- with ENaC control.","evidence":"Co-IP of WNK1-SGK1-mTORC2 ternary complex, kinase-dead mutant, Cl- manipulation, ENaC activity, SGK1 phospho Western","pmids":["36373794"],"confidence":"Medium","gaps":["Structural basis of the scaffolding interaction unknown","Single-lab study"]},{"year":2022,"claim":"Connected WNK1 to angiogenic tight-junction and receptor remodeling, showing WNK1 inhibition blocks TGF-β-driven AXL degradation and that OSR1 binds occludin during junction turnover.","evidence":"WNK1 inhibitor in HUVECs and aortic sprouting, OSR1-occludin Co-IP, AXL degradation assay, embryo vessel extension","pmids":["35867836"],"confidence":"Medium","gaps":["Direct substrates in junction remodeling not mapped","Mechanism of AXL stabilization unclear"]},{"year":null,"claim":"How WNK1 dynamically integrates its chloride-sensing kinase activity with its multiple kinase-independent scaffolding functions (SGK1/mTORC2, EMC assembly, PLC-β/PI4KIIIα) across distinct subcellular compartments remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model spanning kinase and scaffold states","Compartment-specific isoform contributions not integrated","Substrate repertoire in nucleus and during mitosis incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,6,10,37,38]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,5,6,26]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[24,29]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[29,42,43]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[43,41]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,14,41]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,22]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[38]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[41]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[6,10,12,13,37]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,27,43]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[25,28,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[34,42]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[35]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[31,33,40,41]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[38]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,31,40]}],"complexes":["ER membrane protein complex (EMC)","WNK signaling bodies","KLHL3-Cullin3 E3 ligase complex (substrate)"],"partners":["OXSR1","STK39","WNK4","SGK1","KLHL3","NEDD4-2","UVRAG","EMC2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H4A3","full_name":"Serine/threonine-protein kinase WNK1","aliases":["Erythrocyte 65 kDa protein","p65","Kinase deficient protein","Protein kinase lysine-deficient 1","Protein kinase with no lysine 1","hWNK1"],"length_aa":2382,"mass_kda":250.8,"function":"Serine/threonine-protein kinase component of the WNK1-SPAK/OSR1 kinase cascade, which acts as a key regulator of blood pressure and regulatory volume increase by promoting ion influx (PubMed:15883153, PubMed:17190791, PubMed:31656913, PubMed:34289367, PubMed:36318922). WNK1 mediates regulatory volume increase in response to hyperosmotic stress by acting as a molecular crowding sensor, which senses cell shrinkage and mediates formation of a membraneless compartment by undergoing liquid-liquid phase separation (PubMed:36318922). The membraneless compartment concentrates WNK1 with its substrates, OXSR1/OSR1 and STK39/SPAK, promoting WNK1-dependent phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (PubMed:15883153, PubMed:16263722, PubMed:17190791, PubMed:19739668, PubMed:21321328, PubMed:22989884, PubMed:25477473, PubMed:34289367, PubMed:36318922). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A5/KCC2 and SLC12A6/KCC3, regulating their activity (PubMed:16263722, PubMed:21321328). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux (PubMed:19665974, PubMed:21321328). Also acts as a regulator of angiogenesis in endothelial cells via activation of OXSR1/OSR1 and STK39/SPAK: activation of OXSR1/OSR1 regulates chemotaxis and invasion, while STK39/SPAK regulates endothelial cell proliferation (PubMed:25362046). Also acts independently of the WNK1-SPAK/OSR1 kinase cascade by catalyzing phosphorylation of other substrates, such as SYT2, PCF11 and NEDD4L (PubMed:29196535). Mediates phosphorylation of SYT2, regulating SYT2 association with phospholipids and membrane-binding (By similarity). Regulates mRNA export in the nucleus by mediating phosphorylation of PCF11, thereby decreasing the association between PCF11 and POLR2A/RNA polymerase II and promoting mRNA export to the cytoplasm (PubMed:29196535). Acts as a negative regulator of autophagy (PubMed:27911840). Required for the abscission step during mitosis, independently of the WNK1-SPAK/OSR1 kinase cascade (PubMed:21220314). May also play a role in actin cytoskeletal reorganization (PubMed:10660600). Also acts as a scaffold protein independently of its protein kinase activity: negatively regulates cell membrane localization of various transporters and channels, such as SLC4A4, SLC26A6, SLC26A9, TRPV4 and CFTR (By similarity). Involved in the regulation of epithelial Na(+) channel (ENaC) by promoting activation of SGK1 in a kinase-independent manner: probably acts as a scaffold protein that promotes the recruitment of SGK1 to the mTORC2 complex in response to chloride, leading to mTORC2-dependent phosphorylation and activation of SGK1 (PubMed:36373794). Acts as an assembly factor for the ER membrane protein complex independently of its protein kinase activity: associates with EMC2 in the cytoplasm via its amphipathic alpha-helix, and prevents EMC2 ubiquitination and subsequent degradation, thereby promoting EMC2 stabilization (PubMed:33964204) Kinase-defective isoform specifically expressed in kidney, which acts as a dominant-negative regulator of the longer isoform 1 (PubMed:14645531). Does not directly inhibit WNK4 and has no direct effect on sodium and chloride ion transport (By similarity). Down-regulates sodium-chloride cotransporter activity indirectly by inhibiting isoform 1, it associates with isoform 1 and attenuates its kinase activity (By similarity). In kidney, may play an important role regulating sodium and potassium balance (By similarity)","subcellular_location":"Cytoplasm; Nucleus; Cytoplasm, cytoskeleton, spindle","url":"https://www.uniprot.org/uniprotkb/Q9H4A3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/WNK1","classification":"Common Essential","n_dependent_lines":1030,"n_total_lines":1208,"dependency_fraction":0.8526490066225165},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000060237","cell_line_id":"CID001305","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"OXSR1","stoichiometry":10.0},{"gene":"WNK2","stoichiometry":4.0},{"gene":"TIAM1","stoichiometry":0.2},{"gene":"LONP2","stoichiometry":0.2},{"gene":"WNK3","stoichiometry":0.2},{"gene":"RANBP2","stoichiometry":0.2},{"gene":"RCBTB2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001305","total_profiled":1310},"omim":[{"mim_id":"614496","title":"PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E","url":"https://www.omim.org/entry/614496"},{"mim_id":"614495","title":"PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D","url":"https://www.omim.org/entry/614495"},{"mim_id":"614492","title":"PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C","url":"https://www.omim.org/entry/614492"},{"mim_id":"614491","title":"PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B","url":"https://www.omim.org/entry/614491"},{"mim_id":"613115","title":"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B","url":"https://www.omim.org/entry/613115"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/WNK1"},"hgnc":{"alias_symbol":["HSAN2","PPP1R167"],"prev_symbol":["PRKWNK1","HSN2"]},"alphafold":{"accession":"Q9H4A3","domains":[{"cath_id":"3.30.200.20","chopping":"201-304","consensus_level":"medium","plddt":84.8688,"start":201,"end":304},{"cath_id":"1.10.510.10","chopping":"306-480","consensus_level":"medium","plddt":88.023,"start":306,"end":480},{"cath_id":"3.10.20.90","chopping":"487-587","consensus_level":"medium","plddt":87.1887,"start":487,"end":587},{"cath_id":"3.10.20","chopping":"1118-1193_1247-1264","consensus_level":"medium","plddt":80.8697,"start":1118,"end":1264}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H4A3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H4A3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H4A3-F1-predicted_aligned_error_v6.png","plddt_mean":42.66},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=WNK1","jax_strain_url":"https://www.jax.org/strain/search?query=WNK1"},"sequence":{"accession":"Q9H4A3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H4A3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H4A3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H4A3"}},"corpus_meta":[{"pmid":"10828064","id":"PMC_10828064","title":"WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10828064","citation_count":440,"is_preprint":false},{"pmid":"16083423","id":"PMC_16083423","title":"The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16083423","citation_count":435,"is_preprint":false},{"pmid":"24803536","id":"PMC_24803536","title":"Chloride sensing by WNK1 involves inhibition of autophosphorylation.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24803536","citation_count":329,"is_preprint":false},{"pmid":"14610273","id":"PMC_14610273","title":"Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14610273","citation_count":295,"is_preprint":false},{"pmid":"16669787","id":"PMC_16669787","title":"Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16669787","citation_count":262,"is_preprint":false},{"pmid":"17190791","id":"PMC_17190791","title":"Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17190791","citation_count":176,"is_preprint":false},{"pmid":"16006511","id":"PMC_16006511","title":"WNK1 activates SGK1 to regulate the epithelial sodium channel.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16006511","citation_count":170,"is_preprint":false},{"pmid":"15242606","id":"PMC_15242606","title":"Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension.","date":"2004","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/15242606","citation_count":165,"is_preprint":false},{"pmid":"16832045","id":"PMC_16832045","title":"WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16832045","citation_count":158,"is_preprint":false},{"pmid":"16428287","id":"PMC_16428287","title":"Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16428287","citation_count":149,"is_preprint":false},{"pmid":"14645531","id":"PMC_14645531","title":"Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14645531","citation_count":144,"is_preprint":false},{"pmid":"15841204","id":"PMC_15841204","title":"Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15841204","citation_count":143,"is_preprint":false},{"pmid":"12374799","id":"PMC_12374799","title":"Regulation of WNK1 by an autoinhibitory domain and autophosphorylation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12374799","citation_count":131,"is_preprint":false},{"pmid":"14681216","id":"PMC_14681216","title":"WNK1 activates ERK5 by an MEKK2/3-dependent mechanism.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14681216","citation_count":123,"is_preprint":false},{"pmid":"16709664","id":"PMC_16709664","title":"WNK1 kinase isoform switch regulates renal potassium excretion.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16709664","citation_count":113,"is_preprint":false},{"pmid":"23940364","id":"PMC_23940364","title":"WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23940364","citation_count":113,"is_preprint":false},{"pmid":"15060842","id":"PMC_15060842","title":"Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15060842","citation_count":112,"is_preprint":false},{"pmid":"15883153","id":"PMC_15883153","title":"Properties of WNK1 and implications for other family members.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15883153","citation_count":110,"is_preprint":false},{"pmid":"16301342","id":"PMC_16301342","title":"Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population.","date":"2005","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/16301342","citation_count":101,"is_preprint":false},{"pmid":"20921400","id":"PMC_20921400","title":"Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20921400","citation_count":97,"is_preprint":false},{"pmid":"12522152","id":"PMC_12522152","title":"WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12522152","citation_count":96,"is_preprint":false},{"pmid":"16204408","id":"PMC_16204408","title":"Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16204408","citation_count":95,"is_preprint":false},{"pmid":"18521183","id":"PMC_18521183","title":"Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.","date":"2008","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/18521183","citation_count":93,"is_preprint":false},{"pmid":"19644017","id":"PMC_19644017","title":"Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19644017","citation_count":93,"is_preprint":false},{"pmid":"21131289","id":"PMC_21131289","title":"Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21131289","citation_count":85,"is_preprint":false},{"pmid":"34315884","id":"PMC_34315884","title":"Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34315884","citation_count":84,"is_preprint":false},{"pmid":"16081417","id":"PMC_16081417","title":"WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16081417","citation_count":83,"is_preprint":false},{"pmid":"14611643","id":"PMC_14611643","title":"WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14611643","citation_count":83,"is_preprint":false},{"pmid":"29176664","id":"PMC_29176664","title":"GABAA receptor dependent synaptic inhibition rapidly tunes KCC2 activity via the Cl--sensitive WNK1 kinase.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29176664","citation_count":82,"is_preprint":false},{"pmid":"24555568","id":"PMC_24555568","title":"WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24555568","citation_count":80,"is_preprint":false},{"pmid":"15799971","id":"PMC_15799971","title":"Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15799971","citation_count":78,"is_preprint":false},{"pmid":"29237822","id":"PMC_29237822","title":"Potassium-regulated distal tubule WNK bodies are kidney-specific WNK1 dependent.","date":"2017","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/29237822","citation_count":73,"is_preprint":false},{"pmid":"24821705","id":"PMC_24821705","title":"Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24821705","citation_count":72,"is_preprint":false},{"pmid":"16775035","id":"PMC_16775035","title":"WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.","date":"2006","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/16775035","citation_count":71,"is_preprint":false},{"pmid":"22701532","id":"PMC_22701532","title":"A new methodology for quantification of alternatively spliced exons reveals a highly tissue-specific expression pattern of WNK1 isoforms.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22701532","citation_count":68,"is_preprint":false},{"pmid":"16788137","id":"PMC_16788137","title":"Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16788137","citation_count":65,"is_preprint":false},{"pmid":"15350218","id":"PMC_15350218","title":"WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15350218","citation_count":65,"is_preprint":false},{"pmid":"16172412","id":"PMC_16172412","title":"WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.","date":"2005","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/16172412","citation_count":65,"is_preprint":false},{"pmid":"21768522","id":"PMC_21768522","title":"WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.","date":"2011","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/21768522","citation_count":64,"is_preprint":false},{"pmid":"27400149","id":"PMC_27400149","title":"WNK1 kinase balances T cell adhesion versus migration in vivo.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27400149","citation_count":62,"is_preprint":false},{"pmid":"25362046","id":"PMC_25362046","title":"Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25362046","citation_count":61,"is_preprint":false},{"pmid":"25803323","id":"PMC_25803323","title":"New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25803323","citation_count":57,"is_preprint":false},{"pmid":"26241057","id":"PMC_26241057","title":"Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26241057","citation_count":57,"is_preprint":false},{"pmid":"27840899","id":"PMC_27840899","title":"miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27840899","citation_count":56,"is_preprint":false},{"pmid":"29846116","id":"PMC_29846116","title":"Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.","date":"2018","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29846116","citation_count":53,"is_preprint":false},{"pmid":"21220314","id":"PMC_21220314","title":"WNK1 is required for mitosis and abscission.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21220314","citation_count":53,"is_preprint":false},{"pmid":"17392271","id":"PMC_17392271","title":"Biological cross-talk between WNK1 and the transforming growth factor beta-Smad signaling pathway.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17392271","citation_count":52,"is_preprint":false},{"pmid":"17018027","id":"PMC_17018027","title":"Down-regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17018027","citation_count":52,"is_preprint":false},{"pmid":"15686619","id":"PMC_15686619","title":"WNK1: analysis of protein kinase structure, downstream targets, and potential roles in hypertension.","date":"2005","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15686619","citation_count":50,"is_preprint":false},{"pmid":"19363035","id":"PMC_19363035","title":"LINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extension.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19363035","citation_count":49,"is_preprint":false},{"pmid":"23386621","id":"PMC_23386621","title":"WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23386621","citation_count":48,"is_preprint":false},{"pmid":"20813867","id":"PMC_20813867","title":"Regulation of WNK1 expression by miR-192 and aldosterone.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20813867","citation_count":48,"is_preprint":false},{"pmid":"17194447","id":"PMC_17194447","title":"WNK1 and WNK4 modulate CFTR activity.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17194447","citation_count":48,"is_preprint":false},{"pmid":"15309683","id":"PMC_15309683","title":"Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.","date":"2004","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15309683","citation_count":46,"is_preprint":false},{"pmid":"27911840","id":"PMC_27911840","title":"Multistep regulation of autophagy by WNK1.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27911840","citation_count":45,"is_preprint":false},{"pmid":"19244242","id":"PMC_19244242","title":"Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19244242","citation_count":44,"is_preprint":false},{"pmid":"21178395","id":"PMC_21178395","title":"Rice WNK1 is regulated by abiotic stress and involved in internal circadian rhythm.","date":"2011","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21178395","citation_count":43,"is_preprint":false},{"pmid":"32131390","id":"PMC_32131390","title":"WNK1 Kinase Stimulates Angiogenesis to Promote Tumor Growth and Metastasis.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32131390","citation_count":41,"is_preprint":false},{"pmid":"32790646","id":"PMC_32790646","title":"Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32790646","citation_count":41,"is_preprint":false},{"pmid":"16949040","id":"PMC_16949040","title":"Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16949040","citation_count":41,"is_preprint":false},{"pmid":"27009335","id":"PMC_27009335","title":"Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC.","date":"2016","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27009335","citation_count":41,"is_preprint":false},{"pmid":"27025876","id":"PMC_27025876","title":"Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27025876","citation_count":39,"is_preprint":false},{"pmid":"28282258","id":"PMC_28282258","title":"WNK1 is an unexpected autophagy inhibitor.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28282258","citation_count":39,"is_preprint":false},{"pmid":"31022353","id":"PMC_31022353","title":"WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31022353","citation_count":39,"is_preprint":false},{"pmid":"19347040","id":"PMC_19347040","title":"Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19347040","citation_count":39,"is_preprint":false},{"pmid":"15911806","id":"PMC_15911806","title":"Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in French Canadians.","date":"2005","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15911806","citation_count":37,"is_preprint":false},{"pmid":"25171174","id":"PMC_25171174","title":"Zebrafish WNK lysine deficient protein kinase 1 (wnk1) affects angiogenesis associated with VEGF signaling.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25171174","citation_count":37,"is_preprint":false},{"pmid":"15455397","id":"PMC_15455397","title":"A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese family.","date":"2004","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15455397","citation_count":36,"is_preprint":false},{"pmid":"34253593","id":"PMC_34253593","title":"WNK1 Enhances Migration and Invasion in Breast Cancer Models.","date":"2021","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34253593","citation_count":36,"is_preprint":false},{"pmid":"29202451","id":"PMC_29202451","title":"Akt3 inhibits adipogenesis and protects from diet-induced obesity via WNK1/SGK1 signaling.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29202451","citation_count":36,"is_preprint":false},{"pmid":"25145935","id":"PMC_25145935","title":"WNK1 activates large-conductance Ca2+-activated K+ channels through modulation of ERK1/2 signaling.","date":"2014","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/25145935","citation_count":36,"is_preprint":false},{"pmid":"22791335","id":"PMC_22791335","title":"Kidney-specific WNK1 inhibits sodium reabsorption in the cortical thick ascending limb.","date":"2012","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22791335","citation_count":36,"is_preprint":false},{"pmid":"18955660","id":"PMC_18955660","title":"Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues.","date":"2008","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/18955660","citation_count":35,"is_preprint":false},{"pmid":"25477473","id":"PMC_25477473","title":"Generation of WNK1 knockout cell lines by CRISPR/Cas-mediated genome editing.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25477473","citation_count":34,"is_preprint":false},{"pmid":"33964204","id":"PMC_33964204","title":"WNK1 is an assembly factor for the human ER membrane protein complex.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33964204","citation_count":33,"is_preprint":false},{"pmid":"22119528","id":"PMC_22119528","title":"WNK1 promotes PIP₂ synthesis to coordinate growth factor and GPCR-Gq signaling.","date":"2011","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/22119528","citation_count":32,"is_preprint":false},{"pmid":"16816365","id":"PMC_16816365","title":"Cardiovascular expression of the mouse WNK1 gene during development and adulthood revealed by a BAC reporter assay.","date":"2006","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16816365","citation_count":32,"is_preprint":false},{"pmid":"35867836","id":"PMC_35867836","title":"WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35867836","citation_count":31,"is_preprint":false},{"pmid":"15081430","id":"PMC_15081430","title":"Comparison of WNK4 and WNK1 kinase and inhibiting activities.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15081430","citation_count":29,"is_preprint":false},{"pmid":"20937822","id":"PMC_20937822","title":"Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20937822","citation_count":29,"is_preprint":false},{"pmid":"16534117","id":"PMC_16534117","title":"Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type II.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16534117","citation_count":28,"is_preprint":false},{"pmid":"31561038","id":"PMC_31561038","title":"Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders.","date":"2019","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/31561038","citation_count":28,"is_preprint":false},{"pmid":"36373794","id":"PMC_36373794","title":"WNK1 is a chloride-stimulated scaffold that regulates mTORC2 activity and ion transport.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/36373794","citation_count":25,"is_preprint":false},{"pmid":"32174132","id":"PMC_32174132","title":"miR-524-5p inhibits angiogenesis through targeting WNK1 in colon cancer cells.","date":"2020","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32174132","citation_count":25,"is_preprint":false},{"pmid":"21107632","id":"PMC_21107632","title":"Regulation of WNK1 kinase by extracellular potassium.","date":"2010","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/21107632","citation_count":25,"is_preprint":false},{"pmid":"33682442","id":"PMC_33682442","title":"Role of KLHL3 and dietary K+ in regulating KS-WNK1 expression.","date":"2021","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33682442","citation_count":24,"is_preprint":false},{"pmid":"31085334","id":"PMC_31085334","title":"Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.","date":"2019","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/31085334","citation_count":24,"is_preprint":false},{"pmid":"28770829","id":"PMC_28770829","title":"WNK1 is required for proliferation induced by hypotonic challenge in rat vascular smooth muscle cells.","date":"2017","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/28770829","citation_count":24,"is_preprint":false},{"pmid":"23195681","id":"PMC_23195681","title":"Kidney-specific WNK1 regulates sodium reabsorption and potassium secretion in mouse cortical collecting duct.","date":"2012","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23195681","citation_count":22,"is_preprint":false},{"pmid":"23300475","id":"PMC_23300475","title":"WNK1/HSN2 mutation in human peripheral neuropathy deregulates KCC2 expression and posterior lateral line development in zebrafish (Danio rerio).","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23300475","citation_count":21,"is_preprint":false},{"pmid":"18550644","id":"PMC_18550644","title":"Domains of WNK1 kinase in the regulation of ROMK1.","date":"2008","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18550644","citation_count":21,"is_preprint":false},{"pmid":"35649473","id":"PMC_35649473","title":"WNK1 kinase signaling in metastasis and angiogenesis.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/35649473","citation_count":19,"is_preprint":false},{"pmid":"16946995","id":"PMC_16946995","title":"Novel mutation in the HSN2 gene in a Korean patient with hereditary sensory and autonomic neuropathy type 2.","date":"2006","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16946995","citation_count":19,"is_preprint":false},{"pmid":"22080857","id":"PMC_22080857","title":"Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.","date":"2012","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/22080857","citation_count":19,"is_preprint":false},{"pmid":"33048843","id":"PMC_33048843","title":"WNK1 regulates uterine homeostasis and its ability to support pregnancy.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33048843","citation_count":19,"is_preprint":false},{"pmid":"25206073","id":"PMC_25206073","title":"Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1.","date":"2014","source":"Annals of neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/25206073","citation_count":19,"is_preprint":false},{"pmid":"16636245","id":"PMC_16636245","title":"New HSN2 mutation in Japanese patient with hereditary sensory and autonomic neuropathy type 2.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16636245","citation_count":18,"is_preprint":false},{"pmid":"29196535","id":"PMC_29196535","title":"WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription.","date":"2017","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29196535","citation_count":18,"is_preprint":false},{"pmid":"26662201","id":"PMC_26662201","title":"Cell-specific regulation of L-WNK1 by dietary K.","date":"2015","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26662201","citation_count":18,"is_preprint":false},{"pmid":"19739668","id":"PMC_19739668","title":"Kinetic mechanism and inhibitor characterization of WNK1 kinase.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19739668","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53012,"output_tokens":13034,"usd":0.177273,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24395,"output_tokens":10123,"usd":0.187525,"stage2_stop_reason":"end_turn"},"total_usd":0.364798,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"WNK1 is a serine/threonine protein kinase that phosphorylates myelin basic protein and itself, but uniquely lacks the invariant catalytic lysine in subdomain II; instead, Lys-233 in subdomain I performs the catalytic function, as mutation of Lys-233 to Met eliminates kinase activity.\",\n      \"method\": \"In vitro kinase assay with MBP substrate, site-directed mutagenesis (K233M), sequence analysis and structural modeling based on cAMP-dependent protein kinase structure\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay combined with mutagenesis (K233M) directly confirmed the catalytic role of Lys-233; foundational paper replicated by subsequent structural studies\",\n      \"pmids\": [\"10828064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"WNK1 contains an autoinhibitory domain (conserved in all four WNKs) that suppresses kinase-domain activity; mutation of two key residues in this domain attenuates inhibition and increases kinase activity. Autophosphorylation on Ser-382 in the activation loop is required for WNK1 activity.\",\n      \"method\": \"Enzyme fragment analysis, sequence alignment, in vitro kinase assays with autoinhibitory domain constructs, site-directed mutagenesis of activation-loop Ser-382\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with defined fragments and mutagenesis in a single rigorous study; autophosphorylation site confirmed biochemically\",\n      \"pmids\": [\"12374799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"WNK1 activates the ERK5 MAP kinase pathway upstream of MEKK2 and MEKK3: WNK1 overexpression increases ERK5 activity in a MEK5-dependent manner; dominant-negative MEKK2/MEKK3 block this effect; both MEKK2 and MEKK3 co-immunoprecipitate with endogenous WNK1; WNK1 phosphorylates MEKK2 and MEKK3 in vitro and activates MEKK3 in cells; WNK1 siRNA knockdown attenuates EGF-stimulated ERK5 activation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, dominant-negative mutant expression, siRNA knockdown, cotransfection in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, in vitro phosphorylation, and siRNA knockdown with defined phenotypic readout in a single study\",\n      \"pmids\": [\"14681216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of the WNK1 kinase domain at 1.8 Å resolution reveals that the catalytic Lys-233 emanates from strand β2 (not β3 as in all other kinases), the activation loop adopts a unique well-folded inactive conformation, and the overall architecture places WNK1 in a novel structural subfamily of serine/threonine kinases.\",\n      \"method\": \"X-ray crystallography (1.8 Å resolution), homology modeling for substrate-specificity groove identification\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure directly confirms catalytic mechanism and unique active-site architecture; consistent with earlier mutagenesis data\",\n      \"pmids\": [\"15242606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"WNK1 is phosphorylated at Thr-60 by PKB/Akt in response to IGF-1 stimulation; this phosphorylation is PI3K-dependent, occurs on endogenous WNK1, and is abolished in PDK1-null cells where PKB is inactive. Phosphorylation of Thr-60 by PKB does not directly regulate WNK1 kinase activity or localization.\",\n      \"method\": \"Phosphospecific antibody to pThr-60, PI3K inhibitor treatment (wortmannin, LY294002), PDK1-null and PDK1-knock-in ES cell experiments, peptide mapping and mutagenesis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (phosphospecific antibody, inhibitors, genetic null cells) in one rigorous study; negative finding on kinase activity also well-controlled\",\n      \"pmids\": [\"14611643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"WNK1 selectively binds to and phosphorylates synaptotagmin 2 (Syt2) within its C2 calcium-binding domains. Endogenous WNK1 and Syt2 coimmunoprecipitate and colocalize on secretory granules in INS-1 cells. WNK1-mediated phosphorylation at Thr-202 of Syt2 increases the Ca2+ concentration required for Syt2 binding to phospholipid vesicles.\",\n      \"method\": \"Co-immunoprecipitation, colocalization by fluorescence microscopy, in vitro phosphorylation assay, phospholipid-vesicle binding assay, site-directed mutagenesis (T202 mutant)\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation with mutagenesis plus co-IP and functional phospholipid-binding assay; multiple orthogonal methods in one study\",\n      \"pmids\": [\"15350218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 and WNK4 phosphorylate and activate the STE20-family kinases SPAK and OSR1 by phosphorylating the T-loop (Thr-233 in SPAK; Thr-185 in OSR1) and a C-terminal serine (Ser-373 in SPAK; Ser-325 in OSR1). T-loop phosphorylation is required for activation; catalytically inactive WNK1 fails to activate SPAK/OSR1. WNK1 was found associated with SPAK in rat testis immunoprecipitates.\",\n      \"method\": \"Immunoprecipitation from rat testis, in vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis (T185A, T185E, S325A/E in OSR1)\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with phosphopeptide mapping and multiple mutagenesis experiments; foundational paper widely replicated\",\n      \"pmids\": [\"16083423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 activates SGK1 by a PI3K-dependent but non-catalytic mechanism: the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1, and activated SGK1 in turn stimulates the epithelial sodium channel (ENaC) via Nedd4-2 in a WNK1-dependent manner. Phosphorylation of WNK1 Thr-58 contributes to SGK1 activation. WNK1 is also required for IGF-1-induced SGK1 activation.\",\n      \"method\": \"Cotransfection in HEK293/oocytes, deletion mutants of WNK1, PI3K inhibitor (wortmannin), siRNA depletion, Xenopus oocyte ENaC current measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America / The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal functional epistasis, domain deletion mapping, kinase-dead mutants, siRNA knockdown across two independent papers by the same group\",\n      \"pmids\": [\"16006511\", \"16081417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 and WNK4 interact via their kinase domains (shown by co-immunoprecipitation). WNK1 suppresses WNK4-mediated inhibition of the NCC cotransporter; this requires WNK1 catalytic activity and an intact WNK1 protein. A kinase-dead WNK1 associates with WNK4 but fails to suppress WNK4-mediated NCC inhibition. WNK1 also phosphorylates WNK4 and WNK2 in vitro.\",\n      \"method\": \"Co-immunoprecipitation, Xenopus oocyte Na+ flux assay for NCC activity, kinase-dead mutants, deletion constructs, in vitro kinase assay\",\n      \"journal\": \"The Journal of clinical investigation / The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, functional transport assay, kinase-dead controls across two independent studies\",\n      \"pmids\": [\"15841204\", \"15883153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 is identified as a substrate of Akt/PKB in adipocytes; insulin stimulates WNK1 phosphorylation via PI3K/Akt1/Akt2. WNK1 knockdown (siRNA) in 3T3-L1 cells significantly enhances insulin-stimulated thymidine incorporation (~2-fold) and serum-stimulated cell proliferation, identifying WNK1 as a negative regulator of mitogenesis.\",\n      \"method\": \"Immunoprecipitation with anti-pAkt-substrate antibody + mass spectrometry, siRNA depletion of Akt1/Akt2, PI3K inhibitors, thymidine incorporation assay, cell-count proliferation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry identification plus siRNA knockdown with defined functional readout; single lab, two orthogonal methods\",\n      \"pmids\": [\"15799971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 phosphorylates SPAK and OSR1; the CCT (conserved C-terminal) domain of SPAK/OSR1 binds an RFXV motif present in WNK1 (and WNK4), and an intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1. SPAK/OSR1 then phosphorylate NKCC1 at Thr-203/207/212 (human). Mutation of the RFXV-binding residues within the CCT domain inhibits NKCC1 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, peptide binding/affinity purification, site-directed mutagenesis of CCT domain and RFXV motif, phosphopeptide mapping, osmotic-stress stimulation of HEK-293 cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis of both binding partners, multiple substrate phosphorylation sites identified; widely replicated\",\n      \"pmids\": [\"16669787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 is rapidly activated and phosphorylated at multiple sites including the T-loop Ser-382 upon hyperosmotic stress, possibly by transautophosphorylation. Activation coincides with SPAK/OSR1 phosphorylation/activation, and siRNA depletion of WNK1 impairs SPAK/OSR1 activity and phosphorylation under hyperosmotic conditions. Under hyperosmotic stress, WNK1 redistributes from the cytosol to vesicular structures (TGN/recycling endosomes) marked by clathrin, AP-1, and TGN46; the C-terminal non-catalytic domain mediates vesicle localization.\",\n      \"method\": \"siRNA knockdown, phospho-specific antibodies, immunofluorescence colocalization, live-cell imaging, mutational analysis of C-terminal domain, fractionation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA depletion with defined phosphorylation readout, live imaging with colocalization and mutational analysis; multiple orthogonal methods\",\n      \"pmids\": [\"17190791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"OSR1 exists in a complex with WNK1 in cells and is phosphorylated in a WNK1-dependent manner; depletion of WNK1 by siRNA reduces OSR1 kinase activity; depletion of either WNK1 or OSR1 reduces NKCC activity in HeLa cells, placing WNK1 upstream of OSR1 upstream of NKCC1 in a pathway for volume regulation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA depletion of WNK1 and OSR1, in vitro OSR1 activation assay, Rb+ uptake assay for NKCC activity\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, siRNA depletion, in vitro activation, and functional transport assay; independently confirmed by multiple labs\",\n      \"pmids\": [\"16832045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Long WNK1 (L-WNK1) inhibits the ROMK1 potassium channel by stimulating its endocytosis; the N-terminal amino acids 1–491 are sufficient for ROMK inhibition; this inhibition is synergistic with WNK4 but independent of it. The kidney-specific KS-WNK1 isoform lacks inhibitory activity but reverses L-WNK1-mediated ROMK inhibition. Dietary K+ restriction in rats increases L-WNK1 while decreasing KS-WNK1 expression.\",\n      \"method\": \"Xenopus oocyte electrophysiology (ROMK current), truncation constructs of WNK1, dietary K+ manipulation in rats with qRT-PCR/Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional oocyte system with defined domain constructs and in vivo dietary manipulation; replicated by other groups\",\n      \"pmids\": [\"16428287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"KS-WNK1 functions as a dominant-negative regulator of L-WNK1: it forms a protein complex with L-WNK1 in oocytes (co-IP) and attenuates L-WNK1 kinase activity in vitro, leading to downregulation of NCC activity in Xenopus oocytes.\",\n      \"method\": \"Co-immunoprecipitation in Xenopus oocytes, in vitro kinase assay, Xenopus oocyte Na+ flux assay (22Na+ uptake)\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus in vitro kinase inhibition plus functional transport assay; multiple orthogonal methods in one study\",\n      \"pmids\": [\"16204408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 suppresses ROMK surface expression independently of WNK4 in Xenopus oocytes; this effect requires the region encompassing amino acids 502–1100 (containing the acidic motif) and is dynamin-dependent. Surprisingly, a kinase-dead WNK1 (D368A) mimics the effect, indicating ROMK inhibition does not require catalytic activity.\",\n      \"method\": \"Xenopus oocyte ROMK current measurement, kinase-dead mutant (D368A), truncation constructs, dominant-negative dynamin coexpression\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional oocyte assay with multiple WNK1 constructs and dynamin-dominant negative; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"16775035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 and WNK4 suppress CFTR chloride channel activity when coexpressed in Xenopus oocytes. WNK4 reduces CFTR surface expression in a kinase-independent manner. WNK1 suppression of CFTR requires intact WNK1 kinase activity. WNK1 colocalizes with CFTR in pulmonary epithelial cells.\",\n      \"method\": \"Xenopus oocyte electrophysiology (CFTR Cl- current), kinase-dead WNK1, CFTR surface expression assay, immunofluorescence colocalization\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional electrophysiology with kinase-dead mutant and colocalization; single lab\",\n      \"pmids\": [\"17194447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 overexpression in MDCKII cells increases paracellular chloride permeability 2–3-fold and induces phosphorylation of claudin-4, phenocopying effects of disease-causing WNK4 mutants.\",\n      \"method\": \"Stable WNK1-overexpressing MDCKII cell lines, Cl- flux assay, Western blot for phospho-claudin-4\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, stable overexpression with functional Cl- permeability and claudin-4 phosphorylation readouts, but no mechanistic dissection beyond overexpression\",\n      \"pmids\": [\"16949040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WNK1 kinase domain (but not isolated autoinhibitory domain) phosphorylates WNK4 and WNK2 in vitro. WNK1 exists as a tetramer in solution (gel filtration). The WNK1 N-terminus (residues 1–222) interacts with residues 481–660 (autoinhibitory domain + coiled-coil domain) by yeast two-hybrid assay.\",\n      \"method\": \"In vitro kinase assay, gel filtration chromatography, yeast two-hybrid\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — gel filtration and yeast two-hybrid are lower-resolution methods; in vitro phosphorylation of WNK paralogs shown; single lab\",\n      \"pmids\": [\"15883153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"WNK1 directly binds to and phosphorylates Smad2. WNK1 siRNA knockdown in HeLa cells reduces Smad2 protein expression (at least partly by reducing Smad2 transcription), but also causes nuclear accumulation of phosphorylated Smad2 and increased TGF-β-mediated transcriptional responses, identifying WNK1 as a dual modulator of TGF-β–Smad2 signaling.\",\n      \"method\": \"siRNA knockdown of WNK1 in HeLa cells, Western blot for Smad2, immunofluorescence for nuclear pSmad2, in vitro kinase assay, reporter gene assay for TGF-β target genes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus in vitro phosphorylation and transcriptional reporter readout; multiple methods but single lab\",\n      \"pmids\": [\"17392271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The HSN2 exon of WNK1 encodes a nervous system-specific exon; the WNK1/HSN2 isoform is expressed in satellite cells, Schwann cells, and sensory neurons of the peripheral nervous system and is more abundant in sensory neurons than motor neurons. Loss-of-function mutations in this exon cause HSAN type II.\",\n      \"method\": \"Immunodetection (immunofluorescence, IHC) in mouse nervous system tissues, analysis of human WNK1/HSN2 isoform expression, characterization of mutation spectrum\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct immunodetection showing cell-type-specific localization tied to a disease phenotype; characterization of isoform structure\",\n      \"pmids\": [\"18521183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Multiple WNK1 domains interact intramolecularly to regulate ROMK1 inhibition: the N-terminal proline-rich domain (aa 1–119) is necessary and sufficient for ROMK1 inhibition; the N-linker (aa 120–220) antagonizes inhibition; the kinase domain reverses this antagonism via conserved residues Lys-233 and Asp-368 (not kinase activity per se); the autoinhibitory domain (aa 491–555) modulates the kinase domain via two critical Phe residues; and the first coiled-coil (aa 555–640) alleviates the AID effect.\",\n      \"method\": \"Xenopus oocyte ROMK current measurements with WNK1 truncation and point mutants (K233M, D368A, Phe mutations in AID)\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain mapping with mutagenesis in a functional oocyte system; single lab\",\n      \"pmids\": [\"18550644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"WNK1 localizes to cytoplasmic puncta in resting cells and to mitotic spindles during cell division. WNK1 knockdown causes defects in mitotic spindles, abscission failures, and reduced cell survival. These cell-division defects are independent of the WNK1 effector kinase OSR1 (OSR1 knockdown does not cause spindle defects).\",\n      \"method\": \"Immunofluorescence localization (live imaging and fixed cells), siRNA knockdown of WNK1 and OSR1, analysis of mitotic phenotypes (spindle morphology, abscission, survival)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (siRNA knockdown + spindle/abscission phenotype), and negative control (OSR1 KD has no effect); single lab\",\n      \"pmids\": [\"21220314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"WNK1 interacts with LINGO-1 (identified by yeast two-hybrid, validated by FRET and co-IP) in cortical neurons. This interaction is intensified by Nogo66 treatment. WNK1 suppression or overexpression of a dominant-negative WNK1 fragment attenuates Nogo66-induced inhibition of neurite extension and reduces RhoA activation. WNK1 also interacts with Rho-GDI1, an interaction weakened by Nogo66.\",\n      \"method\": \"Yeast two-hybrid screen, FRET, co-immunoprecipitation, siRNA knockdown, RhoA pull-down activity assay, neurite extension assay in cortical neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal binding methods (Y2H, FRET, Co-IP) plus functional siRNA/dominant-negative data; single lab\",\n      \"pmids\": [\"19363035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"WNK1 kinase uses a random sequential mechanism to phosphorylate its substrate OSR1 (OXSR1), as shown by double-reciprocal kinetic analysis. ATP-competitive inhibitors PP1 and PP2 inhibit WNK1 with Ki ~12.7 μM (PP1), acting as pure ATP competitors.\",\n      \"method\": \"Microfluidic capillary-electrophoresis kinase assay, double-reciprocal (Lineweaver-Burk) kinetic analysis, inhibitor competition assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro kinetic mechanism established with a rigorous assay format; single lab, single study\",\n      \"pmids\": [\"19739668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Endothelial-specific deletion of Wnk1 in mice phenocopies global Wnk1 knockout (cardiovascular developmental defects: small heart chambers, reduced trabeculation, defective angiogenesis starting at E10.5); endothelial-specific transgenic rescue of WNK1 corrects these defects, establishing that WNK1 function in endothelial cells is required for angiogenesis and heart development.\",\n      \"method\": \"Conditional endothelial-specific Cre-mediated Wnk1 knockout, transgenic rescue with endothelial WNK1 expression, embryo phenotype analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional knockout plus transgenic rescue constitutes genetic epistasis with defined cellular phenotype; replicated across multiple labs\",\n      \"pmids\": [\"19644017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"WNK1 promotes cell-surface expression of GLUT1 by phosphorylating TBC1D4 (AS160) in vitro, which increases TBC1D4 binding to 14-3-3 proteins and reduces its interaction with the exocytic GTPase Rab8A. This effect requires WNK1 catalytic activity (kinase-dead WNK1 has no effect).\",\n      \"method\": \"Co-immunoprecipitation (WNK1-TBC1D4 complex), in vitro kinase assay, 14-3-3 and Rab8A binding assays, surface GLUT1 expression measurement, kinase-dead WNK1 mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, in vitro phosphorylation, multiple protein-interaction readouts, kinase-dead control; single lab\",\n      \"pmids\": [\"20937822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"WNK1 stimulates PLC-β signaling by promoting synthesis of the PIP2 substrate via activation of phosphatidylinositol 4-kinase IIIα (PI4KIIIα). This effect does not require WNK1 kinase activity and is synergistic with Gαq. WNK1 activity is essential for Gq-coupled receptor regulation of PLC-β. Akt-mediated phosphorylation of WNK1 further amplifies PLC-β signaling via this mechanism.\",\n      \"method\": \"DAG biosensor (TRPC6) and IP3-Ca2+ reporter assays in cells, WNK1 kinase-dead mutant, PI4KIIIα manipulation, Gq inhibitors\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cellular biosensor assays with kinase-dead mutant, multiple signaling pathway manipulations; single lab\",\n      \"pmids\": [\"22119528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"WNK1 activates OSR1 downstream to regulate embryonic angiogenesis and cardiac development: global Osr1 deletion phenocopies Wnk1 knockout (identical yolk-sac and embryo angiogenesis defects from E11); endothelial-specific active-OSR1 transgene rescues cardiovascular defects in global Wnk1-null embryos, establishing a WNK1→OSR1 epistatic axis in embryonic cardiovascular development.\",\n      \"method\": \"Genetic epistasis: global Osr1 knockout, endothelial-specific Osr1 knockout (Tie2-Cre), constitutively active OSR1 knock-in at ROSA26, embryo phenotype analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous genetic epistasis with conditional knockout and transgenic rescue in multiple mouse lines; confirms the WNK1–OSR1 axis in vivo\",\n      \"pmids\": [\"23386621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Chloride directly binds to the catalytic site of WNK1, stabilizing its inactive conformation and inhibiting autophosphorylation. Crystallographic studies of inactive WNK1 in the presence of chloride reveal the Cl- binding site in the active site cavity. Mutagenesis of the chloride-binding site renders WNK1 less sensitive to chloride-mediated inhibition of autophosphorylation, validating WNK1 as a chloride sensor.\",\n      \"method\": \"X-ray crystallography of WNK1 kinase domain with chloride, autophosphorylation assays under varying Cl- concentrations, site-directed mutagenesis of Cl-binding site residues\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with Cl- plus mutagenesis validating the binding site plus biochemical autophosphorylation assay; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"24803536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"WNK1 and its substrate kinase OSR1 have distinct roles in endothelial cells: OSR1 is required for HUVEC chemotaxis and invasion, while SPAK is required for endothelial cell proliferation. WNK1 loss of function impairs cord formation. WNK1 also regulates expression of the transcription factor Slug in endothelial cells.\",\n      \"method\": \"siRNA knockdown of WNK1, OSR1, and SPAK in HUVECs, Matrigel cord-formation assay, chemotaxis/invasion assay, proliferation assay, gene expression analysis for Slug\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts separating OSR1/SPAK functions; single lab\",\n      \"pmids\": [\"25362046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KLHL3 mediates ubiquitination and degradation of WNK1 (and WNK4) as part of the KLHL3-Cullin3 E3 ligase complex; KLHL3 R528H mutation impairs binding to WNK1 and WNK4 peptides, leading to increased WNK1 and WNK4 protein levels and hyperactivation of the WNK→OSR1/SPAK→NCC phosphorylation cascade, causing PHAII.\",\n      \"method\": \"KLHL3 R528H knock-in mouse model, Western blot for WNK1/WNK4 protein levels, fluorescence correlation spectroscopy peptide-binding assay, NCC phosphorylation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knock-in mouse model plus direct peptide-binding assay for KLHL3-WNK1 interaction; multiple methods confirming degradation pathway\",\n      \"pmids\": [\"24821705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"WNK1-OSR1-mediated phosphorylation of NKCC1 is required for regulatory volume increase and promotes glioma cell migration. siRNA-mediated knockdown of WNK1 or OSR1 reduces intracellular K+ and Cl- content, abolishes NKCC1 phospho-activation, and significantly decreases glioma cell migration following temozolomide treatment.\",\n      \"method\": \"siRNA knockdown of WNK1 and OSR1, fluorescent ion indicators for intracellular K+/Cl-, microchemotaxis migration assay, NKCC1 phosphorylation Western blot\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with ion transport and migration functional readouts; single lab\",\n      \"pmids\": [\"24555568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"WNK1 isoforms containing PY-motif-bearing alternatively spliced exons within a proline-rich region are substrates of the E3 ligase NEDD4-2 and are degraded by the ubiquitin-proteasome system. SGK1 (aldosterone-induced kinase) phosphorylates NEDD4-2 and prevents WNK1 degradation, thereby linking aldosterone to activation of the WNK/SPAK/OSR1/NCC pathway. WNK1 deficiency negates regulatory effects of NEDD4-2 and SGK1 on NCC.\",\n      \"method\": \"Identification of PY-motif exons by cDNA analysis, co-IP of WNK1 with NEDD4-2, proteasome inhibitor experiments, SGK1 activity assays, gene-edited WNK1-deficient cells, aldosterone infusion in WT and Nedd4-2 KO mice\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, proteasome inhibition, gene-editing, in vivo aldosterone), linking post-translational regulation to function\",\n      \"pmids\": [\"26241057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"WNK1 negatively regulates integrin-mediated T cell adhesion while positively regulating T cell migration via OXSR1/STK39 (OSR1/SPAK) and SLC12A2 (NKCC1). WNK1-deficient T cells (identified by RNAi screen) home less efficiently to lymphoid organs and migrate more slowly through them.\",\n      \"method\": \"RNAi screen, conditional T cell-specific knockout, cell migration and adhesion assays in vitro, in vivo homing assay to lymphoid organs\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi screen plus conditional knockout with in vitro and in vivo functional readouts; published in high-tier journal with defined pathway placement\",\n      \"pmids\": [\"27400149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"WNK1 inhibits autophagy by multiple mechanisms: WNK1 depletion increases autophagosome formation and autophagic flux, stimulates PI3KC3 complex activity, increases ULK1 expression and AMPK-mediated phosphorylation. The N-terminal region of WNK1 binds UVRAG (a PI3KC3 component) in vitro and WNK1 partially colocalizes with UVRAG; colocalization decreases upon starvation. Depletion of SPAK (but not OSR1) also induces autophagy.\",\n      \"method\": \"siRNA knockdown of WNK1, autophagosome/flux assays, ULK1 expression and phosphorylation Western blot, AMPK activation assay, in vitro binding of WNK1 N-terminus to UVRAG, colocalization by fluorescence microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple downstream readouts and in vitro binding; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"27911840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The KS-WNK1 isoform is critical for WNK body formation in distal tubule cells. WNK bodies are dynamic, membraneless foci distinct from conventional organelles that colocalize with ribosomal protein L22 and cluster WNK signaling components. KS-WNK1 knockout mice fail to form WNK bodies under dietary K+ challenge. A cysteine-rich hydrophobic motif in KS-WNK1's unique N-terminal exon is required for WNK body formation.\",\n      \"method\": \"KS-WNK1 knockout mouse model, live-cell imaging of WNK bodies, colocalization with organelle markers, reconstitution in cell culture, mutagenesis of the cysteine-rich motif\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse plus cell reconstitution plus mutagenesis; single lab with multiple methods\",\n      \"pmids\": [\"29237822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GABA_A receptor-mediated synaptic inhibition regulates KCC2 surface expression via the Cl--sensing kinase WNK1: enhanced GABA_A inhibition confines KCC2 to the plasma membrane, while blocking inhibition increases KCC2 lateral diffusion and endocytosis. This mechanism is dependent on WNK1-mediated phosphorylation of KCC2 at Thr-906 and Thr-1007.\",\n      \"method\": \"Single-particle tracking of KCC2 in hippocampal neurons, pharmacological manipulation of GABA_A activity, phospho-specific antibodies for KCC2 Thr-906/1007, WNK1 inhibitor experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-particle tracking plus pharmacology plus phospho-specific antibodies with functional readout; published in high-tier journal\",\n      \"pmids\": [\"29176664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"WNK1 phosphorylates the transcription termination factor PCF11 on its CID (CTD-interacting domain), and this phosphorylation weakens the CID's interaction with RNA polymerase II CTD, thereby promoting transcript release from chromatin-associated Pol II and facilitating mRNA export.\",\n      \"method\": \"In vitro kinase assay (WNK1 phosphorylation of PCF11 CID), phosphorylation-dependent Pol II CTD binding assay, nuclear WNK1 localization, mRNA export assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay plus Pol II CTD binding assay with functional mRNA export readout; single lab\",\n      \"pmids\": [\"29196535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"WNK1 activates TRPC6-mediated Ca2+ influx by stimulating PI4KIIIα, activating Gαq-coupled/PLC-β signaling and downstream NFATc1, promoting proliferation and migration of clear-cell renal carcinoma cells. Inhibition of WNK1 attenuates TRPC6-mediated Ca2+ influx and NFATc1-dependent gene expression.\",\n      \"method\": \"Patch-clamp electrophysiology for TRPC6 current, Ca2+ imaging, PI4KIIIα activity assay, NFATc1 reporter assay, WNK1 siRNA knockdown and pharmacological inhibition, cell migration/proliferation assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology, Ca2+ imaging, and kinase-pathway analysis with siRNA/inhibitor; single lab\",\n      \"pmids\": [\"31022353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mutations in the conserved acidic motif of WNK1 preferentially impair ubiquitination and degradation of the KS-WNK1 isoform (not L-WNK1) by the KLHL3-CUL3 E3 ligase complex, leading to increased SPAK-NCC phosphorylation cascade activity and impaired ROMK apical expression in the distal nephron, causing a normotenive hyperkalemic hyperchloremic acidosis.\",\n      \"method\": \"Exome sequencing, Xenopus oocyte and HEK293T functional assays for ubiquitination and NCC activity, CRISPR/Cas9 engineered mouse model, renal phospho-NCC and ROMK expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human genetics plus functional cell assays plus CRISPR mouse model with renal molecular phenotyping; multiple orthogonal methods\",\n      \"pmids\": [\"32790646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"WNK1 functions as an assembly factor for the human ER membrane protein complex (EMC): WNK1 uses a conserved amphipathic helix to stabilize the soluble EMC subunit EMC2 by binding at the EMC2-8 interface, shielding a hydrophobic surface from promiscuous interactions and competing with E3 ubiquitin ligases to permit proper EMC assembly. WNK1 depletion destabilizes both EMC and its membrane-protein clients.\",\n      \"method\": \"Biochemical reconstitution, co-immunoprecipitation of WNK1 with EMC2/EMC subunits, structural analysis of amphipathic helix interaction, E3 ligase competition binding assay, WNK1 depletion with analysis of EMC client stability\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution plus structural interface mapping plus E3 ligase competition assay plus depletion phenotype; multiple orthogonal methods; single rigorous study\",\n      \"pmids\": [\"33964204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"WNK1 negatively regulates NLRP3 inflammasome activation and pyroptosis by balancing intracellular Cl- and K+ concentrations. WNK1-deficient macrophages (kinase knockout or protein knockout) show increased NLRP3 activation and pyroptosis. Macrophage-specific WNK1 conditional knockout mice produce more IL-1β in response to NLRP3 stimulation.\",\n      \"method\": \"WNK1 kinase-inactive and protein-knockout macrophages, NLRP3 activation assays (IL-1β secretion, pyroptosis), macrophage-specific conditional knockout mouse model, intracellular Cl-/K+ measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional macrophage KO mouse in vivo plus cell-based kinase and protein knockouts with multiple functional readouts; well-controlled mechanistic link to Cl-/K+ sensing\",\n      \"pmids\": [\"34315884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"WNK1 acts as a chloride-stimulated scaffold (kinase-activity independent) that recruits SGK1 to mTORC2, resulting in enhanced SGK1 phosphorylation and SGK1-dependent ENaC activation. An increase in extracellular K+ raises intracellular Cl-, which triggers this WNK1 scaffolding activity. This effect is selective for SGK1 and does not cause generalized mTORC2 activation.\",\n      \"method\": \"Co-immunoprecipitation of WNK1-SGK1-mTORC2, kinase-dead WNK1 mutant experiments, intracellular Cl- manipulation, ENaC activity assay, SGK1 phosphorylation Western blot\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of ternary complex plus kinase-dead mutant plus ion manipulation with functional ENaC readout; single lab but multiple methods\",\n      \"pmids\": [\"36373794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"WNK1 inhibition prevents TGF-β-dependent degradation of the tyrosine kinase receptor AXL in endothelial cells, and OSR1 (WNK1 substrate) physically interacts with occludin (a tight junction protein), a step required for tight junction turnover during angiogenesis. Both phenomena are WNK1-dependent and TGF-β-sensitive.\",\n      \"method\": \"WNK1 inhibitor treatment of HUVECs and aortic ex vivo sprouting assay, co-immunoprecipitation of OSR1-occludin, AXL expression/degradation assay in presence/absence of WNK1 inhibitor, embryo vessel extension assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for OSR1-occludin, pharmacological WNK1 inhibition with functional angiogenesis and AXL degradation readouts; multiple methods, single lab\",\n      \"pmids\": [\"35867836\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"WNK1 is a structurally unique serine/threonine kinase (catalytic Lys-233 in β2 rather than β3) that functions as a chloride-sensing master regulator: intracellular Cl- directly binds the active site to inhibit autophosphorylation and keep WNK1 inactive, whereas low Cl- allows T-loop (Ser-382) autophosphorylation and activation; active WNK1 then phosphorylates and activates the STE20-family kinases SPAK and OSR1 (via their T-loops and RFXV–CCT docking), which in turn phosphorylate and activate NKCC1/NKCC2 while inhibiting KCC2, thereby coordinating epithelial and neuronal ion homeostasis; WNK1 also activates SGK1 (through a non-catalytic PI3K-dependent scaffolding that recruits SGK1 to mTORC2) to regulate ENaC, phosphorylates synaptotagmin 2 to modulate Ca²⁺-sensing, activates the ERK5 MAPK cascade via MEKK2/3, and inhibits autophagy by binding UVRAG; it undergoes PKB/Akt-mediated phosphorylation at Thr-60 downstream of insulin/IGF-1 and is regulated by ubiquitin-mediated proteasomal degradation through the KLHL3-Cullin3 E3 ligase; additionally, WNK1 serves as an assembly factor for the ER membrane protein complex (EMC) via a conserved amphipathic helix, and in the nucleus it phosphorylates the termination factor PCF11 to facilitate mRNA export; the kidney-specific KS-WNK1 isoform (lacking the kinase domain) antagonizes L-WNK1 by direct protein interaction and is required for formation of membraneless WNK signaling bodies in distal tubule cells, while the nervous-system-specific WNK1/HSN2 isoform regulates KCC2 phosphorylation and is required for peripheral sensory neuron development.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"WNK1 is a structurally atypical serine/threonine kinase that functions as a master regulator of intracellular ion homeostasis and a chloride sensor coupling chloride concentration to cell-signaling output [#0, #29]. It is catalytically unique: the active-site lysine (Lys-233) emanates from strand \\u03b22 rather than \\u03b23, and a high-resolution crystal structure places WNK1 in a novel kinase subfamily with an autoinhibited activation loop [#0, #3]. Activity is gated by autophosphorylation of activation-loop Ser-382, which is relieved from an intramolecular autoinhibitory domain; intracellular chloride binds directly within the active-site cavity to stabilize the inactive state and suppress autophosphorylation, making WNK1 sensitive to changes in Cl- [#1, #29]. The central effector axis is the phosphorylation and activation of the STE20-family kinases SPAK and OSR1, which WNK1 engages through an RFXV motif that docks the SPAK/OSR1 CCT domain and which it activates by T-loop phosphorylation; activated OSR1/SPAK in turn phosphorylate the cation-chloride cotransporter NKCC1 and the K-Cl cotransporter KCC2 to set epithelial and neuronal ion balance [#6, #10, #12, #37]. Through this cascade WNK1 governs cell-volume regulation, NCC/ROMK activity in the distal nephron, T-cell adhesion and migration, and macrophage NLRP3 inflammasome activation via Cl-/K- balancing [#13, #32, #34, #42]. Beyond catalysis, WNK1 acts as a non-catalytic scaffold: it recruits SGK1 to mTORC2 in a chloride-stimulated, kinase-independent manner to activate ENaC, and serves as an assembly factor for the ER membrane protein complex through a conserved amphipathic helix that stabilizes EMC2 [#41, #43]. WNK1 abundance is controlled by ubiquitin-mediated proteasomal degradation through the KLHL3-Cullin3 E3 ligase and through NEDD4-2 acting on PY-motif-bearing isoforms, with both pathways feeding into the WNK\\u2192SPAK/OSR1\\u2192NCC cascade [#31, #33, #40]. WNK1 is required in vivo for endothelial angiogenesis and cardiac development via an OSR1-dependent axis, and tissue-specific isoforms diversify its function: the kinase-domain-lacking KS-WNK1 antagonizes L-WNK1 and nucleates membraneless WNK signaling bodies in distal tubule cells, while a nervous-system-specific WNK1/HSN2 isoform is expressed in peripheral sensory neurons [#25, #28, #36, #20]. Loss-of-function mutations in the WNK1/HSN2 exon cause hereditary sensory and autonomic neuropathy type II, and impaired KLHL3/KS-WNK1 degradation underlies pseudohypoaldosteronism type II [#20, #40].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that WNK1 is an active serine/threonine kinase with an unprecedented catalytic architecture, answering whether and how a kinase lacking the canonical subdomain-II lysine could function.\",\n      \"evidence\": \"In vitro kinase assay on MBP plus K233M mutagenesis and structural modeling\",\n      \"pmids\": [\"10828064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates not yet identified\", \"Regulation of activity in cells unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined how WNK1 activity is controlled, showing an autoinhibitory domain suppresses the kinase and that activation-loop Ser-382 autophosphorylation is required for activity.\",\n      \"evidence\": \"In vitro kinase assays with autoinhibitory-domain fragments and Ser-382 mutagenesis\",\n      \"pmids\": [\"12374799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal triggering activation not defined\", \"Whether autophosphorylation is cis or trans unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Provided atomic-resolution confirmation of the unique active-site geometry (Lys-233 from \\u03b22) and an inactive activation-loop conformation, placing WNK1 in a distinct structural subfamily.\",\n      \"evidence\": \"X-ray crystallography of the WNK1 kinase domain at 1.8 \\u00c5\",\n      \"pmids\": [\"15242606\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of active/phosphorylated state not captured\", \"No substrate-bound complex\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected WNK1 to MAPK signaling by showing it acts upstream of MEKK2/3 to activate the ERK5 cascade, broadening its role beyond ion transport.\",\n      \"evidence\": \"Reciprocal Co-IP, in vitro phosphorylation of MEKK2/3, dominant-negative and siRNA in HEK293\",\n      \"pmids\": [\"14681216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of ERK5 activation by WNK1 unclear\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed WNK1 downstream of insulin/IGF-1 signaling by identifying PKB/Akt phosphorylation at Thr-60, while showing this does not directly alter kinase activity.\",\n      \"evidence\": \"Phosphospecific antibody, PI3K inhibitors, PDK1-null cells, peptide mapping\",\n      \"pmids\": [\"14611643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Thr-60 phosphorylation initially unclear\", \"Downstream effectors of this input not defined here\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified a neuronal/secretory substrate, synaptotagmin 2, demonstrating WNK1 can tune Ca2+-sensing of vesicle fusion machinery.\",\n      \"evidence\": \"Co-IP, colocalization on granules, in vitro phosphorylation at Thr-202, phospholipid-binding assay\",\n      \"pmids\": [\"15350218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance to secretion not established\", \"Cell-type specificity of this function unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the core effector axis: WNK1 phosphorylates and activates SPAK and OSR1 via their T-loops, establishing the kinase cascade that controls ion cotransporters.\",\n      \"evidence\": \"In vitro kinase assay, phosphopeptide mapping, T-loop/C-terminal mutagenesis, testis IP\",\n      \"pmids\": [\"16083423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate selection mechanism not fully defined\", \"In vivo cotransporter consequences shown later\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed a non-catalytic scaffolding function in which WNK1's N-terminus activates SGK1 (PI3K-dependent) to stimulate ENaC via Nedd4-2, distinguishing kinase-independent from kinase-dependent WNK1 roles.\",\n      \"evidence\": \"Domain deletions, kinase-dead mutants, siRNA, Xenopus oocyte ENaC currents\",\n      \"pmids\": [\"16006511\", \"16081417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular details of SGK1 recruitment defined later\", \"Chloride dependence not yet appreciated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed WNK kinases interact and cross-regulate, with catalytically active WNK1 suppressing WNK4-mediated NCC inhibition, linking WNK1 to renal sodium handling.\",\n      \"evidence\": \"Co-IP, kinase-dead controls, in vitro phosphorylation of WNK paralogs, oocyte Na+ flux\",\n      \"pmids\": [\"15841204\", \"15883153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo NCC regulation by WNK1 not directly tested here\", \"Stoichiometry of WNK1-WNK4 complex unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified WNK1 as an Akt substrate in adipocytes and a negative regulator of mitogenesis, linking insulin signaling to proliferation control.\",\n      \"evidence\": \"Anti-pAkt-substrate IP/MS, siRNA, thymidine incorporation and proliferation assays in 3T3-L1\",\n      \"pmids\": [\"15799971\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which WNK1 restrains proliferation unknown\", \"Single cell-line context\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the docking logic of the WNK\\u2192SPAK/OSR1\\u2192NKCC1 cascade, showing the SPAK/OSR1 CCT domain binds the WNK1 RFXV motif and is required for efficient substrate phosphorylation.\",\n      \"evidence\": \"In vitro kinase assays, peptide-binding, CCT/RFXV mutagenesis, NKCC1 phosphosite mapping\",\n      \"pmids\": [\"16669787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How osmotic stress triggers WNK1 not yet at chloride-level detail\", \"Other RFXV-bearing partners not enumerated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placed WNK1 functionally upstream of OSR1 and NKCC in cell-volume regulation and showed osmotic-stress-induced WNK1 activation and vesicular relocalization.\",\n      \"evidence\": \"Co-IP, siRNA of WNK1/OSR1, in vitro OSR1 activation, Rb+ uptake, live imaging and fractionation\",\n      \"pmids\": [\"16832045\", \"17190791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct osmosensing mechanism not yet defined\", \"Functional role of vesicular relocalization unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established L-WNK1 versus KS-WNK1 isoform antagonism in the kidney, showing L-WNK1 inhibits ROMK endocytically (partly kinase-independent) while KS-WNK1 reverses this, defining isoform-based regulation of renal K+ handling.\",\n      \"evidence\": \"Oocyte ROMK electrophysiology, truncations, kinase-dead (D368A), dynamin DN, Co-IP, dietary K+ in rats\",\n      \"pmids\": [\"16428287\", \"16204408\", \"16775035\", \"18550644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of intramolecular domain regulation incomplete\", \"In vivo ROMK regulation tied to physiology shown later\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended WNK1's channel-regulatory reach to CFTR and paracellular permeability, indicating broad control of epithelial chloride flux.\",\n      \"evidence\": \"Oocyte CFTR currents with kinase-dead WNK1; MDCKII Cl- flux and phospho-claudin-4\",\n      \"pmids\": [\"17194447\", \"16949040\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab overexpression systems\", \"Direct substrate of claudin-4 phosphorylation not shown to be WNK1\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified WNK1 as a dual modulator of TGF-\\u03b2\\u2013Smad2 signaling, binding and phosphorylating Smad2 and controlling its levels and nuclear activity.\",\n      \"evidence\": \"siRNA, Western blot, nuclear pSmad2 immunofluorescence, in vitro kinase, reporter assay in HeLa\",\n      \"pmids\": [\"17392271\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphosite on Smad2 not mapped\", \"Transcriptional versus post-translational contributions intertwined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterized the nervous-system-specific WNK1/HSN2 isoform and linked its loss-of-function to hereditary sensory and autonomic neuropathy type II, tying WNK1 to peripheral sensory neuron biology.\",\n      \"evidence\": \"Immunodetection in mouse nervous tissue, human isoform expression and mutation spectrum analysis\",\n      \"pmids\": [\"18521183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular function of HSN2 isoform not defined\", \"Mechanism linking mutations to neuropathy unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed an OSR1-independent role of WNK1 in mitosis, with localization to spindles and knockdown causing spindle and abscission defects.\",\n      \"evidence\": \"Immunofluorescence/live imaging, siRNA of WNK1 and OSR1, mitotic phenotype analysis\",\n      \"pmids\": [\"21220314\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mitotic substrates of WNK1 not identified\", \"Mechanism of spindle association unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected WNK1 to neuronal Nogo/RhoA inhibitory signaling through interaction with LINGO-1 and Rho-GDI1, implicating it in neurite outgrowth control.\",\n      \"evidence\": \"Y2H, FRET, Co-IP, siRNA, RhoA pull-down, neurite extension in cortical neurons\",\n      \"pmids\": [\"19363035\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether kinase activity is required not resolved\", \"Single-lab interaction data\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the enzymatic mechanism of WNK1 toward OSR1 as random sequential and characterized ATP-competitive inhibition, enabling biochemical inhibitor work.\",\n      \"evidence\": \"Microfluidic capillary-electrophoresis kinase assay, Lineweaver-Burk kinetics, PP1/PP2 competition\",\n      \"pmids\": [\"19739668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Inhibitors are non-selective tool compounds\", \"Single in vitro study\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established the WNK1\\u2192OSR1 axis as essential for embryonic angiogenesis and cardiac development in vivo via genetic epistasis and endothelial rescue.\",\n      \"evidence\": \"Global and endothelial Wnk1/Osr1 knockouts, constitutively active OSR1 knock-in rescue, embryo phenotyping\",\n      \"pmids\": [\"19644017\", \"23386621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of OSR1 in endothelium not fully defined here\", \"Cotransporter contribution to vascular phenotype unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified chloride as a direct allosteric ligand binding the WNK1 active site to inhibit autophosphorylation, establishing WNK1 as a bona fide chloride sensor.\",\n      \"evidence\": \"X-ray crystallography with Cl-, autophosphorylation assays across Cl- concentrations, Cl--site mutagenesis\",\n      \"pmids\": [\"24803536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How physiological Cl- transients are integrated in cells not fully resolved\", \"Other ion sensitivities not excluded\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected the WNK1-OSR1-NKCC1 axis to disease-relevant cell behavior, showing it drives glioma volume regulation and migration.\",\n      \"evidence\": \"siRNA of WNK1/OSR1, intracellular K+/Cl- indicators, NKCC1 phospho Western, migration assays\",\n      \"pmids\": [\"24555568\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo tumor relevance not tested\", \"Single cell-context\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined ubiquitin-mediated control of WNK1 abundance by the KLHL3-Cullin3 ligase, and showed disease mutations stabilizing WNK1 hyperactivate the NCC cascade in PHAII.\",\n      \"evidence\": \"KLHL3 R528H knock-in mouse, peptide-binding (FCS), WNK1/WNK4 Western, NCC phosphorylation\",\n      \"pmids\": [\"24821705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degron determinants on WNK1 not fully mapped here\", \"Isoform selectivity of degradation addressed later\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissected divergent roles of WNK1 effectors in endothelial cells, with OSR1 driving chemotaxis/invasion and SPAK driving proliferation, plus regulation of Slug.\",\n      \"evidence\": \"siRNA of WNK1/OSR1/SPAK in HUVECs, cord-formation, chemotaxis/invasion, proliferation, gene expression\",\n      \"pmids\": [\"25362046\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Slug regulation unknown\", \"Single-lab cell-based data\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linked aldosterone signaling to WNK1 stability, showing SGK1-phosphorylated NEDD4-2 spares PY-motif WNK1 isoforms from degradation to activate the NCC pathway.\",\n      \"evidence\": \"PY-motif exon analysis, Co-IP with NEDD4-2, proteasome inhibition, gene-edited cells, aldosterone infusion in mice\",\n      \"pmids\": [\"26241057\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution relative to KLHL3 pathway unclear\", \"Isoform-specific effects not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established a physiological immune role, with WNK1 (via OXSR1/STK39 and SLC12A2) negatively regulating T-cell adhesion while promoting migration and lymphoid homing.\",\n      \"evidence\": \"RNAi screen, T-cell conditional knockout, adhesion/migration assays, in vivo homing\",\n      \"pmids\": [\"27400149\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TCR/chemokine signals activate WNK1 in T cells not fully defined\", \"Chloride-sensing contribution in T cells unaddressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified WNK1 as a negative regulator of autophagy, acting partly through binding the PI3KC3 component UVRAG and through SPAK.\",\n      \"evidence\": \"siRNA, autophagosome/flux assays, ULK1/AMPK Western, in vitro WNK1 N-terminus\\u2013UVRAG binding, colocalization\",\n      \"pmids\": [\"27911840\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether kinase activity is required not fully resolved\", \"Direct versus indirect effects on PI3KC3 unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated a nuclear, transcription-associated function: WNK1 phosphorylates the termination factor PCF11 to weaken its Pol II CTD interaction and promote transcript release and mRNA export.\",\n      \"evidence\": \"In vitro kinase on PCF11 CID, phosphorylation-dependent CTD binding, nuclear localization, mRNA export assay\",\n      \"pmids\": [\"29196535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance for gene expression not established\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed WNK1 couples GABA_A inhibitory activity to KCC2 surface stability via phosphorylation at Thr-906/1007, integrating chloride sensing with neuronal inhibition.\",\n      \"evidence\": \"Single-particle tracking of KCC2, GABA_A pharmacology, phospho-specific antibodies, WNK1 inhibition\",\n      \"pmids\": [\"29176664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus SPAK/OSR1-mediated KCC2 phosphorylation not fully separated\", \"In vivo neuronal consequences not tested here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established that the KS-WNK1 isoform nucleates membraneless WNK signaling bodies in distal tubule cells, providing a spatial organizing principle for the pathway under K+ challenge.\",\n      \"evidence\": \"KS-WNK1 knockout mouse, live imaging, colocalization, cell reconstitution, cysteine-rich motif mutagenesis\",\n      \"pmids\": [\"29237822\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biophysical basis of body formation incompletely defined\", \"Functional output of WNK bodies on signaling not fully quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed WNK1 drives TRPC6-mediated Ca2+ influx via PI4KIII\\u03b1/PLC-\\u03b2/NFATc1, promoting renal carcinoma proliferation and migration, extending the non-catalytic PLC pathway to cancer.\",\n      \"evidence\": \"Patch-clamp, Ca2+ imaging, PI4KIII\\u03b1 activity, NFATc1 reporter, siRNA/inhibitor, migration assays\",\n      \"pmids\": [\"31022353\", \"22119528\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo tumor relevance not established\", \"Kinase-independence of the full pathway not exhaustively tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Refined disease genetics by showing acidic-motif mutations selectively impair KS-WNK1 (not L-WNK1) degradation by KLHL3-CUL3, causing a hyperkalemic hyperchloremic acidosis via NCC and ROMK dysregulation.\",\n      \"evidence\": \"Exome sequencing, oocyte/HEK293T ubiquitination and NCC assays, CRISPR mouse, renal phospho-NCC/ROMK analysis\",\n      \"pmids\": [\"32790646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of isoform-selective degron recognition not fully resolved\", \"Quantitative contribution of ROMK versus NCC to phenotype unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Uncovered a kinase-independent moonlighting role as an EMC assembly factor, with a WNK1 amphipathic helix stabilizing EMC2 against degradation to permit ER membrane protein complex assembly.\",\n      \"evidence\": \"Reconstitution, Co-IP with EMC2/EMC subunits, interface structural analysis, E3-ligase competition, depletion of EMC clients\",\n      \"pmids\": [\"33964204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How this function is partitioned from ion-signaling roles unknown\", \"In vivo importance not assessed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established WNK1 as a brake on innate immune activation, negatively regulating NLRP3 inflammasome and pyroptosis by balancing intracellular Cl-/K+.\",\n      \"evidence\": \"Kinase-inactive and protein-knockout macrophages, IL-1\\u03b2/pyroptosis assays, macrophage-specific conditional KO mouse, ion measurement\",\n      \"pmids\": [\"34315884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative roles of kinase versus scaffold functions partially defined\", \"Direct effector linking WNK1 to NLRP3 not pinpointed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined the molecular basis of WNK1-mediated SGK1 activation as chloride-stimulated scaffolding that recruits SGK1 to mTORC2 selectively, integrating extracellular K+/intracellular Cl- with ENaC control.\",\n      \"evidence\": \"Co-IP of WNK1-SGK1-mTORC2 ternary complex, kinase-dead mutant, Cl- manipulation, ENaC activity, SGK1 phospho Western\",\n      \"pmids\": [\"36373794\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the scaffolding interaction unknown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected WNK1 to angiogenic tight-junction and receptor remodeling, showing WNK1 inhibition blocks TGF-\\u03b2-driven AXL degradation and that OSR1 binds occludin during junction turnover.\",\n      \"evidence\": \"WNK1 inhibitor in HUVECs and aortic sprouting, OSR1-occludin Co-IP, AXL degradation assay, embryo vessel extension\",\n      \"pmids\": [\"35867836\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct substrates in junction remodeling not mapped\", \"Mechanism of AXL stabilization unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How WNK1 dynamically integrates its chloride-sensing kinase activity with its multiple kinase-independent scaffolding functions (SGK1/mTORC2, EMC assembly, PLC-\\u03b2/PI4KIII\\u03b1) across distinct subcellular compartments remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model spanning kinase and scaffold states\", \"Compartment-specific isoform contributions not integrated\", \"Substrate repertoire in nucleus and during mitosis incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 6, 10, 37, 38]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 5, 6, 26]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [24, 29]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [29, 42, 43]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [43, 41]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 14, 41]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 22]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [38]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [41]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [6, 10, 12, 13, 37]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 27, 43]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [25, 28, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [34, 42]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [35]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [31, 33, 40, 41]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [38]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 31, 40]}\n    ],\n    \"complexes\": [\"ER membrane protein complex (EMC)\", \"WNK signaling bodies\", \"KLHL3-Cullin3 E3 ligase complex (substrate)\"],\n    \"partners\": [\"OXSR1\", \"STK39\", \"WNK4\", \"SGK1\", \"KLHL3\", \"NEDD4-2\", \"UVRAG\", \"EMC2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}